Treatment-Specific Approaches for Analysis and Control of Left Ventricular Assist Devices by Faragallah, George
University of Central Florida 
STARS 
Electronic Theses and Dissertations, 2004-2019 
2014 
Treatment-Specific Approaches for Analysis and Control of Left 
Ventricular Assist Devices 
George Faragallah 
University of Central Florida 
 Part of the Electrical and Electronics Commons 
Find similar works at: https://stars.library.ucf.edu/etd 
University of Central Florida Libraries http://library.ucf.edu 
This Doctoral Dissertation (Open Access) is brought to you for free and open access by STARS. It has been accepted 
for inclusion in Electronic Theses and Dissertations, 2004-2019 by an authorized administrator of STARS. For more 
information, please contact STARS@ucf.edu. 
STARS Citation 
Faragallah, George, "Treatment-Specific Approaches for Analysis and Control of Left Ventricular Assist 
Devices" (2014). Electronic Theses and Dissertations, 2004-2019. 4774. 
https://stars.library.ucf.edu/etd/4774 
TREATMENT-SPECIFIC APPROACHES FOR ANALYSIS AND 
CONTROL OF LEFT VENTRICULAR ASSIST DEVICES 
 
 
 
by: 
 
 
GEORGE FARAGALLAH 
B.S. Cairo University, 2005 
M.S. University of Central Florida, 2009 
 
 
 
A dissertation submitted in partial fulfillment of the requirements  
for the degree of Doctor of Philosophy 
in the department of Electrical Engineering and Computer Science 
in the College of Engineering and Computer Science 
at the University of Central Florida 
Orlando, Florida 
 
 
 
 
Fall Term 
2014 
 
 
 
Major Professor: Marwan A. Simaan 
 
  
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 George Faragallah 
  
iii 
 
ABSTRACT 
A Left Ventricular Assist Device (LVAD) is a mechanical pump that helps patients with 
heart failure conditions. This rotary pump works in parallel to the ailing heart and provides an 
alternative path for blood flow from the weak left ventricle to the aorta. The LVAD is controlled 
by the power supplied to the pump motor. An increase in the pump motor power increases the 
pump speed and the pump flow. The LVAD is typically controlled at a fixed setting of pump 
power. This basically means that the controller does not react to any change in the activity level 
of the patient. An important engineering challenge is to develop an LVAD feedback controller 
that can automatically adjusts its pump motor power so that the resulting pump flow matches the 
physiological demand of the patient. To this end, the development of a mathematical model that 
can be used to accurately simulate the interaction between the cardiovascular system of the 
patient and the LVAD is essential for the controller design. The use of such a dynamic model 
helps engineers and physicians in testing their theories, assessing the effectiveness of prescribed 
treatments, and understanding in depth the characteristics of this coupled bio-mechanical system. 
The first contribution of this dissertation is the development of a pump power-based 
model for the cardiovascular-LVAD system. Previously, the mathematical models in the 
literature assume availability of the pump speed as an independent control variable. In reality, 
however, the device is controlled by pump motor power which, in turn, produces the rotational 
pump speed. The nonlinear relationship between the supplied power and the speed is derived, 
and interesting observations about the pump speed signal are documented. 
The second contribution is the development of a feedback controller for patients using an 
LVAD as either a destination therapy or a bridge to transplant device. The main objective of 
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designing this controller is to provide a physiological demand of the patient equivalent of that of 
a healthy individual. Since the device is implanted for a long period of time, this objective is 
chosen to allow the patient to live a life as close to normal as possible. 
The third contribution is an analysis of the aortic valve dynamics under the support of an 
LVAD. The aortic valve may experiences a permanent closure when the LVAD pump power is 
increased too much. The permanent closure of the aortic valve can be very harmful to the 
patients using the device as a bridge to recovery treatments. The analysis illustrates the various 
changes in the hemodynamic variables of the patient as a result of aortic valve closing. The 
results establish the relationship between the activity level and the heart failure severity with 
respect to the duration of the aortic valve opening.  
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CHAPTER 1: THE CARDIOVASCULAR SYSTEM MODEL 
The development of mathematical models requires complete understanding of the process 
that is being modeled. For this reason, we begin this chapter by giving a brief overview of the 
cardiovascular system. Much emphasis is given to the heart and the cardiac cycle because they 
are responsible for regulating the blood flow. The similarities between the dynamics of blood 
through blood vessels and Ohm’s law for electrical circuits are outlined. This is followed by 
introducing the lumped-parameter electrical circuit model of the cardiovascular system. Then 
using control theory laws, the model is then formulated in the space state representation form. 
1.1. The Cardiovascular System     
The cardiovascular system consists of blood, blood vessels and the heart. In general terms, 
the main task of the cardiovascular system is to satisfy, for each individual cell of the organism, 
the requirements of metabolism for O2 and other substrates. At the same time CO2 and the other 
end products of metabolism have to be removed [1].  
First part of the cardiovascular system is the blood. Blood is a viscous fluid that 
represents about 8% of the total body weight. On the average, males have blood volume of 5 to 6 
liters, while females have 4 to 5 liters. Blood is constantly circulating the human body through 
blood vessels. Its flow through the blood vessels is powered by the force created by the pumping 
action of the heart. The flow in the straight blood vessels is mostly a laminar flow, but it turns to 
turbulent when it is distributed at the branching points in the vessels to reach the different organs 
of the body. Hence, the main function of the blood is to carry oxygen, nourishments, electrolytes, 
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hormones and vitamins to the body tissues; and collect carbon dioxide and waste away from 
them. Additional functions for the blood include: protecting the body from infections (helping 
the immune system); regulating the temperature of the body; and stopping the bleeding of open 
wounds (coagulation). 
Second part of the cardiovascular system is the blood vessels. They are the channels 
through which blood reaches the body tissues. Blood vessels form two main distribution 
networks: the first is the systemic circulation which carries the oxygenated blood from the left 
side of the heart to the rest of the body and then the oxygen-depleted blood goes back to the right 
side of the heart; and the second is the pulmonary circulation, which carries the oxygen-depleted 
blood from the right side of the heart to the lungs for oxygen exchange and then carries the 
oxygen rich blood back to the left side of the heart. Together they are called the circulatory 
system and they form a closed loop system which starts and ends at the heart. Figure 1.1 shows 
the cardiovascular system. The blood vessels where the oxygenated blood flow is shown in red 
while blue indicates the vessels that carry the deoxygenated blood. In addition to the two main 
circulations, there is the coronary circulation. Its task is to supply the oxygenated blood to the 
heart muscle. The blood vessels of the coronary circulation run on the surface or deep into the 
heart muscle. Most of the blood delivery to the heart muscle happens when the heart muscle is 
relaxed, because that is when the vessels can increase their diameter. 
In terms of their structure and function, the blood vessels can be classified into three main 
groups: arteries; capillaries and veins. Arteries carry blood away from the heart, either to body 
tissues (called systemic arteries) or to the lungs (called pulmonary arteries). The largest artery, in 
terms of diameter, is the aorta which carries the oxygenated blood as it leaves the left ventricle 
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and then it branches out to smaller arteries. These smaller arteries branch to even smaller blood 
vessels called arterioles; they help regulate the blood flow into the tissue capillaries. Capillaries 
have the smallest diameter among blood vessels. They are considered to be the link between 
arteries and veins. Their task is to facilitate the exchange of material between the blood and the 
tissue cells. Veins are the blood vessels that carry blood towards the heart. As opposed to the 
arteries, the blood flows first in veins with the smallest diameter (called venules) after it leaves 
the capillaries, then it flows into veins that has larger diameter. It finally reaches the two main, 
and largest diameter, veins: superior vena cava; and inferior vena cave, together they are called 
venae cavae. 
Finally, the third part of the cardiovascular system is the heart. It is a muscular organ that 
weighs about 250~300 grams [2], and is located behind and slightly left to the breastbone. Its 
main task is to pump blood into the blood vessels which, in turn, deliver the blood to the various 
organs in the body [3]. 
The heart can be divided to four chambers: right atrium, right ventricle (together can be 
called right heart), left atrium and left ventricle (together can be called left heart), see Figure 1.2. 
The two atria are thin-walled chambers that receive blood from the veins, where the two 
ventricles are thick-walled chambers that can pump blood into the arteries. The flow is regulated 
through four valves: two in the left heart (mitral and aortic valve); and two in the right heart 
(tricuspid and pulmonary valve). Mitral and tricuspid valves are the atria and the ventricles, 
where the aortic and pulmonary valves are between the ventricles and the arteries. The right and 
left hearts work in concert to pump blood it into the circulatory system. The sequence of events 
taking place inside the heart to achieve this task is called the cardiac cycle [3]. 
4 
 
 
Figure 1.1: Human Circulatory System. 
(http://en.wikipedia.org/wiki/File:Circulatory_System_en.svg) 
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1.2. The Cardiac Cycle 
The cardiac cycle is a term that refers to the sequence of events related to the heart from 
the beginning of one heartbeat to the beginning of the next one. In literature there are different 
ways to divide the cardiac cycle into phases. Some references use two main phases, while others 
can be more specific and list as many as eight different phases. However, when the focus is on 
the dynamics of the valve, using four phases can fully describe the cardiac cycle, as seen in 
Table 1.1. 
The cardiac cycle is better explained by following the blood pressure, blood flow and the 
state of the valves in each phase. Focusing on the left heart side, the four phases are: 
1.2.1. Isovolumic Relaxation 
In this phase, the ventricle relaxes and its pressure is rapidly decreasing without any 
change in the blood volume inside the ventricle, hence the name isovolumic. This happens due to 
the closure of the mitral and the aortic valve in this phase. Blood form the pulmonary veins fills 
the left atrium and that causes a gradual increase in the left atrial pressure, but is still lower than 
the left ventricle pressure and that keeps the mitral valve closed during the entire phase. Across 
the aortic valve the aortic pressure is higher than the left ventricle pressure and that leads to the 
closure of the aortic valve. 
1.2.2. Filling 
In this phase, the left ventricle pressure continues to decrease until its value is lower than 
the left atrial pressure. This change in the pressure difference leads to the opening of the mitral 
valve and the blood flowing from the left atrium to fill the left ventricle. Initially the blood from 
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the atrium flows rapidly, but then it slows down until the filling is complete. The left ventricle 
pressure is increasing in a very small rate during this phase, but still lower than the aortic 
pressure, hence the aortic valve remains to be closed. 
1.2.3. Isovolumic Contraction 
The mitral valve closes when the pressure in the left ventricle exceeds the left atrial 
pressure. Now both valves are closed again, but in this phase the left ventricle pressure is rapidly 
increasing (i.e. the ventricle muscle is contracting). The aortic pressure continues to decrease 
because of the closure of the aortic valve. 
1.2.4. Ejection 
As the pressure inside the left ventricle continues to build up and exceeds the aortic 
pressure, the aortic valve opens in response to this change in pressure. This causes the blood to 
be ejected (pumped) from the left ventricle into the aorta. As the blood volume inside the 
ventricle starts decreases, the blood is ejected in a slower rate until it stops when the pressure in 
the ventricle is lower than that in the aorta. The mitral valve state remains unchanged (i.e. closed) 
during this phase. 
 Figure 1.3 shows the pressure and volume measurements of the left heart during two 
cardiac cycles. Note that the same sequence of events happens simultaneously in the right heart, 
but pressures of the right ventricle, right atrium and the pulmonary artery are lower than that of 
the left ventricle, left atrium and the aorta, respectively. The reason is that the left ventricle is 
stronger than the right ventricle, as it needs to pump blood to the whole body whereas the right 
ventricle pumps blood to the lungs. 
7 
 
 
 
 
 
Figure 1.2: Cross Section of a Beating heart  
(http://upload.wikimedia.org/wikipedia/commons/e/e5/Diagram_of_the_human_heart_(cropped).svg) 
 
 
Table 1.1: Phases of the Cardiac Cycle 
Modes 
Valves 
Phases 
Mitral/Tricuspid Aortic/Pulmonary 
1 Closed Closed Isovolumic Relaxation 
2 Open Closed Filling 
1 Closed Closed Isovolumic Contraction 
3 Closed Open Ejection 
- Open Open Not Feasible 
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Figure 1.3: Cardiac Cycle  
(Source: http://en.wikipedia.org/wiki/File:Cardiac_Cycle_Left_Ventricle.PNG) 
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It is important to give formal definitions for some parameters and concepts related to the 
cardiac cycle since they will be used repeatedly in this dissertation [4]: 
1. Heart Rate ( )HR : is the number of heartbeats per unit time, commonly known as beats 
per minute (bpm). When calculating HR in bpm, Equation(1.1) can be used: 
60
c
HR
t
          (1.1) 
Where ct is the time interval for one cardiac cycle. 
2. Systole: means the contraction of the heart and it describes the events that happen during 
the isovolumic contraction and ejection phases of the cardiac cycle.  
3. End Systolic Volume ( )ESV : is the blood volume inside the ventricle at the end of the 
systole. It is the lowest volume of blood during the cardiac cycle, thus it can be used 
clinically to measure the ventricle ability to pump blood. 
4. Diastole: means the relaxation of the heart and it describes the events that happen during 
the isovolumic relaxation and filling phases of the cardiac cycle.  
5. End Diastolic Volume ( )EDV : is the blood volume inside the ventricle at the end of the 
diastole. 
6. Stroke Volume ( )SV : is the blood volume that is pumped by the ventricle in one beat. It 
can be calculated as the difference between the end-diastolic volume of blood and the 
end-systolic volume of blood. 
SV EDV ESV          (1.2) 
7. Cardiac Output (CO): Is the blood volume ejected by the ventricle per unit time. It is 
common to use the units of ml/s or l/min. 
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*CO SV HR          (1.3) 
8. Ejection Fraction (EF): Is the fraction of the end diastolic volume that is pumped during 
every heartbeat. In other words, what percentage of the blood volume stored in the 
ventricle, during the isovolumic contraction, is pumped to the aorta during the ejection 
phase. 
f
SV EDV ESV
E
EDV EDV

              (1.4) 
1.3. Electrical Analogue of the Cardiovascular System 
There are many similarities between the flow of blood into blood vessels and the electric 
current passing through conductors. The blood flow ( )Q  depends on two factors: the pressure 
difference ( )P between the two ends of the blood vessel, and the impediment (resistance) 
( )vascR to the blood flow through the vessel. Equation (1.5) describes such relation: 
vasc
P
Q
R

            (1.5) 
This expression is similar to Ohm’s law which describes the relation between the electric 
current ( )I and the voltage difference ( )V and electric resistance R of the conductor as described 
in Equation(1.6): 
V
I
R
            (1.6) 
The volume-pressure relationship is called the vascular compliance, and it is a measure of 
the ability of a blood vessel wall to expand and contract in response to changes in pressure. It is 
important to model the vascular compliance for large arteries and veins, the compliance effect 
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can be neglected, however, in small arteries. The compliance is described in Equation (1.7) as 
the change of volume ( )Vol (The volume is denoted as Vol  to avoid any confusion with the 
voltage) divided by the change in pressure ( )P : 
vasc
Vol
C
P



          (1.7)  
In order to relate the flow rate to the compliance, Equation (1.7) can be rearranged and 
then the derivative is taken in respect to time for both sides. 
( )
( )
dVol t dP
Q t C
dt dt
          (1.8) 
The capacitance can be used to model the vascular compliance since it describes how 
much charge ( )q can be stored on a capacitor for a given voltage as in Equation(1.9). The 
relationship between the current and the voltage applied on a capacitor is described by 
Equation(1.10): 
q
C
V



           (1.9) 
( )
( )
dv t
i t C
dt
           (1.10) 
The blood inertance ( )vascL relates the pressure drop with the rate of change of flow as in 
Equation(1.11). When the blood is subjected to a pressure difference the velocity of the blood 
changes and, in turns, the flow rate changes. In large blood vessels the inertance has more effect, 
while in small arteries it is the resistance that is more effective [7].  
( )
( ) vasc
dQ t
P t L
dt
           (1.11)  
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The blood inertance can be modeled using the concept of inductance in electric circuits. 
The relationship between the self-inductance of an inductor ( )L , current passing through it and 
voltage is: 
( )
( )
di t
v t L
dt
           (1.12) 
Equations (1.6), (1.10) and (1.12) can be used to model the hemodynamic relations 
described in Equations (1.5),  (1.8) and (1.11), respectively. 
1.4. The Cardiovascular System Model 
A mathematical model is a complete and consistent set of mathematical equations that 
can describe an entity. This entity may be physical, mechanical, biological, physiological or 
conceptual [5]. In many disciplines there is a need to use such models to experiment theories 
before they are applied to real world applications. This testing and simulation process helps 
engineers modify and improve their designs with the least amount of loss in time, money, effort 
or in some cases life. Additionally, a model can help in describing the underlying changes in the 
entity (the inverse problem) using the input-output data relation in the model. Lately, there has 
been a rapid advancement in the modeling of biomedical applications, thanks to the use of 
technology to collect and process huge amount of data needed to develop an accurate model [1]. 
The entity in our research is the cardiovascular system which can be first modeled into a 
lumped-parameter electrical circuit model and then using laws from circuit theory we can 
translate it into a set of differential equations [6]. 
Various models have been developed in the literature during the last few decades. The 
model complexity is determined primarily by the application for which the model is used. In this 
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chapter a lumped-parameter circuit model is used which describes only the left side of the heart 
with the systemic circulation. The reasons behind not modeling the pulmonary circulation and 
the right heart are related to the application discussed in this dissertation, and these reasons will 
be explained in more details in the next chapters. 
The model used in this dissertation is an electrical circuit model that was developed in 
[8]-[10], and is shown in Figure 1.4. In Table 1.2 all the parameters of the model are listed along 
with their physiological meaning and a standard value is given (when applicable). 
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Figure 1.4: Fifth Order Circuit Model That Represents the Cardiovascular System 
 
 
 
 
Table 1.2: Model Parameters [8]-[10] 
Parameters Value Physiological Meaning 
Resistances (mmHg٠s/ml)  
SR  1.0000 Systemic Vascular Resistance (SVR) 
MR  0.0050 Mitral valve resistance 
AR  0.0010 Aortic valve resistance 
CR  0.0398 Characteristic resistance 
Compliances (ml/mmHg)  
( )C t  Time-
varying 
Left ventricle compliance 
RC  4.4000 left atrial compliance 
SC  1.3300  
AC  0.0800  
Inertances (mmHg٠s2/ml)  
SL  0.0005 Inertance of blood in aorta 
Valves (no units)  
MD  - Mitral valve 
AD  - Aortic valve 
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The parameters listed in Table 1.2 are well explained and an algorithm for the estimation 
process is provided in [11]. It is important, however, to explain three of the parameters in more 
details since these parameters will be used extensively in this dissertation. 
1. Systemic Vascular Resistance: 
Systemic Vascular Resistance ( )SVR , also referred to as SR in Figure 1.4, is the 
total resistance of the systemic circulation to the blood flow. When SVR  increases, 
arterial pressure also increases which, in turn, reduces the cardiac output, and vice versa 
[12]. The overall diameter of the blood vessels in the systemic circulation is the most 
important factor that affects SVR . As a result of a complex physiological process, SVR
decreases during exercise allowing more blood flow into the circulation, but SVR
increases during rest[13],[14].  
The pressure difference across the systemic circulation equals the mean arterial 
pressure ( )MAP minus the central venous pressure ( )CVP (it is the pressure inside the 
vena cava, and it determines the amount of blood returned to the heart), and the total 
blood flow is the cardiac output ( )CO [15]. Using these variables in Equation (1.5) yields 
an expression for determining SVR : 
MAP CVP
SVR
CO

         (1.13) 
Usually the value of CVP is very small and can be neglected, which reduces 
Equation (1.13) into: 
MAP
SVR
CO
          (1.14) 
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SVR is represented in the model by an electrical resistance SR . The value for SR
can be varied to simulate different level of activates for the body. Small values of 
SR  are 
used to simulate high level of activity (such as fast walking or running, for example), 
while high values are used to simulate low level of activity (such as rest or sleeping, for 
example). In our model, we use a value of 
SR =1.0 mmHg٠s/ml to represent a normal 
activity level.  
2. Left Ventricular Compliance 
The elastance function ( )E t is a measure of how the left ventricle reacts according 
to the four phases of the cardiac cycles mentioned in Table 1.1. ( )E t is the time-varying 
parameter that can be calculated by Equation(1.15) and it describes the relationship of left 
ventricle pressure  ( )LVP t to the left ventricle volume ( )LVV t  and a reference volume 
OV  [16],[17]. The Left Ventricle compliance ( )C t is the reciprocal of the elastance 
function of the heart.  
( )
( )
( ) O
LVP t
E t
LVV t V


          (1.15)
1
( )
( )
C t
E t

         
(1.16) 
The left ventricle can be viewed as an elastic bag that expands and contracts based 
on the differential pressure on it.  
The elastance function ( )E t can be approximated mathematically.  In our work we 
use the expression(1.17): 
 max min min( ) ( ) ( )nE t E E E t E         (1.17) 
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Where ( )n nE t is the normalized elastance (also called “double hill” function) 
represented by the following expression [18]: 
 
1.9
1.9 21.9
10.7
( ) 1.55* *
1 1
0.7 1.17
n
n n
n n
t
E t
t t
    
    
    
      
       
      
   (1.18) 
In (1.18), max/nt t T , max 0.2 0.15* cT t  and ct  is the cardiac cycle interval, i.e., 
60 /ct HR , where HR is the heart-rate. Notice that ( )E t is a re-scaled version of ( )n nE t
and the constants maxE and minE are related to the end-systolic pressure volume 
relationship (ESPVR) and the end-diastolic pressure volume relationship (EDPVR) 
respectively. For a healthy heart max 2 mmHg/mlE   and min 0.06 mmHg/mlE  , but for 
a heart with a cardiovascular disease maxE  can be assigned a value less than 2 mmHg/ml 
to simulate such case. The lower the maxE value, the less elastance the ventricle has, hence 
simulating a more severe heart disease. 
Figure 1.5 shows the elastance function of the left ventricle over one cardiac cycle 
for three different cases: (1) Healthy heart max( 2 mmHg/ml)E   shown in the plot as red 
solid line, (2) Heart with mild heart failure condition max( 1 mmHg/ml)E  shown in the 
plot as blue solid line with dotted data markers, and (3) Heart with severe heart failure 
condition max( 0.25 mmHg/ml)E  shown in the plot as black dashed line. All plots are 
considered for 60 beat/minHR  which results in a cardiac cycle time of 1 sct  . 
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Figure 1.5: Elastance Function of healthy, mild heart failure and severe heart failure Left Ventricle 
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3. Mitral and Aortic Valves 
The mitral and aortic valves are represented by two non-ideal diodes consisting of 
a resistance MR and ideal diode MD for the mitral valve, and resistance AR  and ideal 
diode 
AD for the aortic valve, as shown in Figure 1.4. 
Any Ideal diode is either short circuit or open circuit depending on the voltage 
across it. If the diode is short circuit, it can simulate the valve being open, and for a 
closed valve, the diode is open circuit. 
 
The differential equations that govern the circuit model in Figure 1.4 have been derived 
in [8]. The state space representation of the model is shown in Equation(1.19) with the state 
variables of the system listed in Table 1.3.  
1 1
2
2 2
3 3
4 4
5 5
( )
0 0 0 0 1 1
( )
( ) ( )1 1
0 0 0 1
10
1 1 1
0 0 0 0
1
01
0 0 0 0
0 0
1 1
0 0
S R S R
R
M
S S S S S
A
A
C
S S S
C t
C t
C t C t
x xR C R C r xx x C
R
x x
R C R C Cx x
x x C
C
R
L L L
 
  
  
                 
       
      
         
  
  
    
  
 
 
1
1 4
1
A
x
r x x
R
 
 
 
 
  
 
(1.19) 
 
Note that in (1.19) the non-linearity caused by the diodes is represented by the ramp 
function ( )r   described in(1.20): 
 if 0( ) 0 if 0r              (1.20) 
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This ramp function ( )r  allows the model to simulate the four phases of the cardiac cycle. 
For instance in the contraction and relaxation phases, LVP is greater than LAP and AoP is 
greater than LVP , and this causes both valves to be closed. This translates in the model to 1( )x t is 
greater than 2 ( )x t and 4 ( )x t is greater than 1( )x t , and, in turn, the two ramp function 2 1( )r x x
and 1 4( )r x x are equal to zero making MD and AD open circuit, respectively. In the filling phase, 
however, 1( )x t  is greater than 4 ( )x t , and this leads 1 4( )r x x to have a value equals to the voltage 
difference across the diode MD and its resistance MR . Similarly, in the ejection phase 2 1( )r x x
will have a value equals to the voltage difference across the diode AD and its resistance AR . 
1.5. Summary 
In this chapter, we reviewed the cardiovascular system and in particular the heart. The 
events that happen during the cardiac cycle is outlined and important medical definitions are 
given. A lumped-parameter model of the cardiovascular system of a healthy subject is presented. 
Using Kirchhoff’s voltage and current laws, five differential equations were formulated to give 
the mathematical model that can accurately represent the left side of the heart and the systemic 
circulation. The reasons for not including the pulmonary circulation and the right heart in the 
model are related to the application of this research. As it will be clearer from chapter 2, the 
engineering problem we discuss in this dissertation is focused on patients with left-sided heart 
failure. Assuming that the pulmonary circulation and the right heart are healthy helps in making 
the model less complex. It still, however, accurately models the left heart and the systemic 
circulation. 
21 
 
 
 
Table 1.3: State Variables in the Cardiovascular Model 
Variables Names Physiological Meaning (unit) 
1( )x t  ( )LVP t  Left Ventricular Pressure (mmHg) 
2 ( )x t  ( )LAP t  Left Atrial Pressure (mmHg) 
3( )x t  ( )AP t  Arterial Pressure (mmHg) 
4 ( )x t  ( )AoP t  Aortic Pressure (mmHg) 
5( )x t  ( )TQ t  Total Flow (ml/s) 
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CHAPTER 2: THE LEFT VENTRICULAR ASSIST DEVICES 
The Left Ventricular Assist Device (LVAD) is one of the available treatment options for 
heart failure patients. It is mechanical pump that is connected between the left ventricle and the 
aorta, and helps in providing adequate blood flow to the patient. Developing a mathematical 
model for the LVAD can help researchers and engineers to understand and test their theories 
before they are applied to patients. The chapter begins with a brief introduction of the heart 
failure problem. Details about the LVAD types, its construction and the different treatments for 
which it can be used, are given. Then The LVAD pump is represented by a 1
st
 order circuit 
model. The pump model is combined with the 5
th
 order cardiovascular model from the previous 
chapter to form the complete cardiovascular-LVAD model.  
2.1. Heart Failure 
The American Heart Association (AHA) estimates that 5.8 million patients above the age 
of 20 in the United States are suffering from Heart Failure [19], a condition in which the heart is 
no longer able to pump enough blood to meet the physiological needs of the body. It is a chronic, 
progressive condition that is difficult to detect at the early stages because, at first, the heart and 
the body work together to try to make up for the inadequate blood supply. The heart can 
compensate by pumping faster than usual or developing more muscle mass to pump stronger, 
while the body can narrow the blood vessels to raise the blood pressure and can divert the blood 
from less vital tissue to more important ones. These measures taken by both the heart and the 
body are only temporary. Once they cannot keep up with the workload, symptoms such as 
exercise intolerance and fatigue start to appear.  
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Heart failure can occur due to: diseases that can damage the heart –including coronary 
heart disease, high blood pressure, and diabetes- are common causes of heart failure; and/or 
unhealthy habits like smoking, being overweight, unhealthy food diet, and physical inactivity.  
Heart failure can affect the right side of the heart (called right-sided heart failure), the left 
side of the heart (called left-sided heart failure), or both sides (called bi-ventricular heart failure) 
[21]. In this dissertation, the focus is on the left-sided heart failure and its treatment. Left-sided 
heart failure can be further divided into two types: systolic failure, which is the inability of the 
ventricle to contract normally to pump enough blood into the circulation; and diastolic failure, 
which is the inability of the ventricle to relax normally to be filled with blood during the 
relaxation phase. 
The estimated total of direct and indirect cost of heart failure in the United States for 
2008 is $34.8 billion dollars with the greatest share being hospitalization. Treatments that can 
lead to patients being discharged from hospitals faster can reduce this cost, and hence there is 
more research and funds aimed at these treatments. The next section will explain how the LVAD 
is one of these treatments that can cut the cost of heart failure. Other treatments for heart failure 
include: medications, bypass surgery, heart valve surgery, and heart transplant. For severe heart 
failure patients, heart transplant is the best long term therapy. In the United States there are 
100,000 patients suitable for heart transplant, but only 2200 operations performed annually due 
to the shortage in available donors [20]. The unbalance between donors and recipients presses 
the need for alternative treatments that can replace heart transplant or temporarily support the 
patient for usual long periods of time on the transplant list.   
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2.2. Left Ventricular Assist Devices 
The LVAD is a mechanical pump that is connected between the left ventricle and the 
aorta through two cannulae. It is designed to help the left ventricle of the patient in pumping 
blood in higher rates from the weak ventricle to the aorta. The LVAD pump is implanted just 
below the diaphragm in the abdomen. A tube that passes through the skin connects the pump 
with a system controller unit and the battery pack that provides power, both are wearable devices.   
2.2.1. LVAD Generations 
The LVAD is classified into two generations based on the pump technology used in them. 
The first generation pumps are pulsatile pumps, which mimic the pumping action of the heart. In 
detail, the pulsatile pumps consist of two mechanical valves and a pusher-plate pump. When 
blood fills the ventricle, it creates pressure forcing one of the pump valves to open and then 
blood fills the pumping chamber. After the valve closes, a force will be applied rapidly to push 
the plates to decrease the pump chamber volume. The pressure increase inside the chamber 
causes the blood to be pumped through the second mechanical valve into the aorta. These pumps 
have the drawbacks of being less durable, bulky and noisy. In addition, they cause bleeding, 
infections, thrombo-embolic events and technical failures [22]. 
The second generation, however, is a continuous flow pumps that don’t operate on the 
fill-and-empty concept, but rather has blood flowing through the pump continuously [23]. They 
are smaller in size, produce less noise and much more durable than the first generation pumps. It 
is better mainly because it contains less moving parts and no mechanical valves are needed, 
hence less maintenance and lower probability of malfunction occurring. The flow is generated by 
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the motion of a central rotor that contains permanent magnets and controlled by electric current 
that runs through coils contained in the pump housing. Unlike the first generation, the second 
generation pumps change the hemodynamic conditions of the patients because of the continuous 
flow doesn’t resemble the intermittent flow by the native heart [24]. Continuous flow pumps 
used in the LVAD are either centrifugal pumps or axial pumps. The centrifugal pumps are 
shaped in a way that the blood –or generally speaking, any fluid– enters the pump chamber 
perpendicular to the rotor axis direction and the blades cause the blood to accelerate 
circumferentially and exit through an outlet. In the axial flow pumps, the blood flows in the same 
direction of the axis of the rotor. 
The pump used later in the model, explained in sections 3 and 4, is a second generation 
axial flow pump.  
2.2.2. LVAD Components 
Regardless of the pump technology used, the LVAD has the following important 
components [22], [25]: 
1. Inlet cannula: a tube that connects the left ventricle to the pump. It is surgically attached 
to the walls of the left ventricle during the operation of implanting the LVAD. 
2. A mechanical pump: this is considered as the main part of the LVAD system. And it is 
well explained in the previous section.  
3. Outlet cannula: a tube that connects the pump chamber to the ascending aorta. 
4. Controller: its function is to control motor power and speed, provide redundant system 
operation, monitor the performance of the system, records and store events in memory, 
and to give warnings and alarms when necessary. Under the current technology the 
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controller is set to provide constant flow rate that meets the baseline physiological 
demand of the patient [49]. A feedback controller that can respond to the changes in the 
physiological state of the patient is essential for the advancement in the LVAD treatment. 
In addition, the controller should be able to detect and avoid the suction phenomenon. 
Suction happens when the pump speed is too high that it attempts to draw more blood 
from the ventricle than available. This can cause severe damage to the heart muscle. 
5. Power source: a set of two rechargeable batteries that can be worn by the patient with a 
shoulder strap. One battery supply the power to the controller unit and the other is a 
backup. The battery level can be monitored from the screen of the controller unit.  
6. Driveline:  it is a thin tube that runs from the controller unit and passes through the skin 
to the pump in order to provide the current needed to control the rotational speed of the 
pump. 
Figure 2.1 shows all the components of an LVAD, note that the pump in this figure is an 
axial flow pump, but the figure can be applicable for any other types of pump. 
2.2.3. LVAD treatment strategies 
There are three different types of treatment where the LVAD can be used. Two are 
intended for temporary support: bridge to transplant and bridge to recovery. The third treatment 
is aimed at permanent support and it is called destination therapy. 
First type of treatment is Bridge to Transplant (BTT). In this type of treatment, the 
LVAD is used to maintain and improve the ventricular function and perfusion in patients waiting 
for heart transplant. It is essential to use this kind of the support because of the long waiting 
period between getting on the recipient list and the availability of a suitable heart. BTT is used 
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for patients hospitalized with end-stage heart failure. The LVAD allows those patients to be 
discharged from the hospital and return home while waiting for the donor heart. 
Second is Bridge to Recovery (BTR). This is a new application for the LVAD. It was 
recently observed that the LVAD support for some patients is accompanied by hemodynamic 
and physiologic changes that are indicative of recovery [28]. Some studies credit the continuous 
unloading of the left ventricle as a factor that can help the reverse remodeling process (i.e. 
recovery) [29], [30].  
Third and final type is Destination Therapy (DT). In some cases heart transplant 
operations are not possible due to age or condition. In such cases the LVAD is suitable adjunct 
therapy to heart transplant and is used to support the heart failure patients for the rest of their 
lives [22]. As a result of recent studies [32],[33] showing that the LVAD has a better two-year 
survival rate over medical therapy, the FDA approved the LVAD for DT in the US. 
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Figure 2.1: Schematic of a rotary LVAD 
(source: Thoratec) 
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2.3. The Left Ventricular Assist Device Model    
The LVAD pump considered in this dissertation is a second generation axial-flow blood 
pump that is driven by a DC motor. The rotation of the impellor of the pump causes a high 
pressure difference that forces the blood to flow from the inlet cannula to the outlet cannula [34].  
This pressure difference between the left ventricle and the aorta can be expressed as the sum of 
pressure differences across the inlet cannula
iH , the pump PH and the outlet cannula oH , that is: 
 ( ) ( ) i P oLVP t AoP t H H H          (2.1) 
The terms on the right hand side in Equation (2.1) are defined in [35]as: 
( )
( ) Pi i P i
dQ t
H R Q t L
dt
          (2.2) 
2( )( ) ( )PP P P P
dQ t
H R Q t L t
dt
  
       
(2.3) 
( )
( ) Po o P o
dQ t
H R Q t L
dt
          (2.4) 
The parameter  is a pump-dependent constant and ( )t is the pump rotational speed. 
The parameters PR , iR  and oR represent the resistances and PL , iL and oL  represents the inertances 
of the pump, inlet cannula and outlet cannula, respectively.  
We note, however, that when suction occurs another term needs to be added to 
Equation(2.1) to account for the resistance of the flow due to suction. In case of suction 
Equation(2.1) will be: 
( ) ( ) ( )i P o K PLVP t AoP t H H H R Q t           
(2.5) 
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KR is a function of ( )LVP t  because when suction happens LVP decreases significantly 
causing the blood volume inside the ventricle to decrease. This phenomenon can be represented 
by a non-linear resistance [50] in the form of: 
  11 1
0 if ( )
( ) if ( )K
LVP t x
R
LVP t x LVP t x


 
      (2.6) 
In Equation(2.6),  is a cannula-dependent scaling factor and 1x is a suction threshold. If 
LVP is less than or equal this threshold, then the value of KR will increase linearly as a function 
of the difference between LVP and 1x . 
 Using Equations(2.3), (2.2) and (2.4) to simplify (2.5) yields: 
 * * 2
( )
( ) ( ) ( ) ( )PP
dQ t
LVP t AoP t R Q t L t
dt
         (2.7) 
Where: 
*
K P i oR R R R R            (2.8) 
And 
*
P i oL L L L            (2.9) 
Figure 2.2 shows the circuit model for the LVAD pump and Table 2.1 lists all the 
parameters in the LVAD along with a typical value and the physiological meaning for each. 
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Figure 2.2: LVAD Pump Model 
 
 
Table 2.1: Model Parameters for the LVAD 
Parameters Value Physiological Meaning 
Resistances (mmHg٠s/ml)  
iR  0.0677 Inlet resistance of cannulae 
PR  
0.17070 Pump resistance 
oR  0.0677 Outlet resistance of cannulae 
KR  see (2.6) Suction resistance with parameters: 
 =-3.5s/ml and 1x =1mmHg 
Inertances (mmHg٠s2/ml)  
iL  0.0127 Inlet inertance of cannulae 
PL  
0.02177 Pump intertance 
oL  
0.0127 Outlet inertance of cannulae 
Constants (mmHg/rpm
2
)  
  9.9025*10
-7 
Pump-dependent constant 
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2.4. The Combined Cardiovascular-LVAD Model 
A combined model of the LVAD and cardiovascular system has been derived in [8]. By 
adding the model of the LVAD to the cardiovascular system we add one state variable 
corresponding to the blood flow in the pump ( )PQ t ; which we will denote as. By rearranging 
Equation (2.7) and replacing ( )LVP t , ( )AoP t and ( )PQ t with 1( )x t , 4 ( )x t and 6 ( )x t , respectively, 
the differential equation for the 1
st
 order pump model can be written as: 
*
6 1 4 6* * * *
1 1
( ) ( ) ( ) ( ) ( )
R
x t x t x t x t u t
L L L L

          (2.10) 
Where 2( ) ( )u t t is used to denote the control variable in the model. 
Combining Equations (1.19) and (2.10) yields the 6
th
 order mathematical model that fully 
represents the interaction between the cardiovascular system and the LVAD. Such model can be 
represented, using control terminology, in the standard state-space form: 
( ) ( ) ( ) ( ) ( ) ( )x t A t x t P t p x b u t          (2.11) 
Where: 
*
* * *
( ) 1
0 0 0 0
( ) ( )
1 1
0 0 0 0
1 1 1
0 0 0
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1 1
0 0 0 0
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0 0 0
1 1
0 0 0
S R S R
S S S S S
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C
S S S
C t
C t C t
R C R C
R C R C CA t
C C
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R
L L L
  
 
 
 
 
 
 
 
 
 
 
 
 
  
  
    (2.12) 
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     (2.13) 
And, 
*
0
0
0
0
0
b
L

 
 
 
 
 
 
 
 
          (2.14) 
 This is a non-linear time-varying model that is controlled by increasing or decreasing the 
rotational speed of the pump can also be regarded as a bio-mechanical coupled system where the 
dynamics of the heart and the pump are interconnected, each influencing the other. 
Figure 2.3 shows the complete 6
th
 order circuit model of the cardiovascular system and 
the LVAD pump. This model is basically the 5
th
 order model that was presented in chapter 1 
with the 1
st
 order model of the pump connected between the ventricle and the aorta. 
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Figure 2.3: Combined Cardiovascular and LVAD Model 
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2.5. Summary 
In this chapter, we presented a 1
st
 order model to represent the pump. This model was 
derived from the equation that describes the pressure difference between the left ventricle and the 
aorta. The phenomenon of suction was accounted for by adding a nonlinear resistance
KR . 
During normal operation,
KR is equal to zero. When suction occurs, however, KR  represents the 
resistance to the flow due to the unavailability of blood in the ventricle. The pump model was 
added to the 5
th
 order cardiovascular model yielding a 6
th
 order model that can represent the 
combined cardiovascular-LVAD model. This model is controlled by the rotational speed of the 
pump. In reality, the pump is controlled by the pump motor current, which controls the pump 
speed. In the next chapter, we reformulated the combined cardiovascular-LVAD model in such a 
way so as to introduce the pump motor current instead of the pump speed as the independent 
control variable to the model.      
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CHAPTER 3: NEW POWER-BASED CONTROL MODEL OF THE PUMP 
OF THE LEFT VENTRICULAR ASSIST DEVICES 
The model discussed in Chapter 2 was derived based on the assumption that the pump 
speed is the independent control variable that is available for controlling the performance of the 
system. While this may be acceptable from a theoretical point of view, in practice, however, the 
pump is controlled by varying the electrical power supplied to the LVAD pump. In this chapter, 
we reformulate the 6
th
 order model to have the pump power as the independent control variable. 
A relationship between the pump power and the pump speed is derived. Finally, simulation 
results are shown to validate the model and to explore the characteristics of the pump speed 
signal during normal operation and suction.  
3.1. The Power-Based Pump Model 
From the previous chapter, we know that Equation (2.7) can be written as: 
 * *
( )
( ) ( ) ( ) PP
dQ t
LVP t AoP t R Q t L H
dt
   
      
(3.1) 
The direct relation between the electrical power delivered to the motor ( )EP and the 
hydrodynamic power generated by the pump ( )PP can be used to determine the pressure head H  
in (3.1) as follows:  
P EP P           (3.2) 
Where   is the electric to hydrodynamic power transfer efficiency. The hydrodynamic 
power can be written as the product of the density of the reference fluid  , acceleration of 
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gravity g , pump head H , and flow rate ( )pQ t  through the pump. Therefore equation (3.2) can be 
written as:        
( )P Eg H Q t P              (3.3) 
Solving for H  yields: 
( )
E
P
P
H
Q t
           (3.4) 
Where
g



 . The parameters listed in the previous equations are defined and typical 
values are given in Table 3.1. Note that the LVAD used in our model assumes that all energy 
losses are accounted for by the pressure losses induced by pR  and pL , and subsequently   is 
assumed to be 100%.  
Substituting Equation (3.4) in (3.1) yields the state equation that governs the behavior of 
the LVAD pump, see Equation(3.5). 
* * ( )( ) ( ) ( )
( )
P E
P
P
dQ t P
LVP t AoP t R Q t L
dt Q t
          (3.5) 
Note that EP is the only control variable in the entire model. It can be changed by either 
manipulating the current I  or the voltage V  across the DC motor of the pump according to the 
relationship EP VI .  
In order to develop a complete power-based model, a relationship has to be found 
between the pump power and the rotational speed of the pump. From Equation(2.7), the pump 
head pressure is given by: 
2( )H t           (3.6) 
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Using Equations(3.4) and(3.6), and solving for the rotational pump speed [37]: 
( )
( )
E
P
P
t
Q t



          (3.7) 
This relationship is highly nonlinear, and because of the dependence on ( )PQ t , a constant 
value of power applied to the LVAD motor will not lead to a constant rotational speed on the 
pump. Instead, the rotational speed of the pump will be periodic in nature as determined by 
equation (3.7) since ( )PQ t is periodic. This phenomenon will be further explained in the next 
sections. It should be noted that when referencing the rotational speed that corresponds to a value 
of EP , we actually mean the average value of ( )t  over its period. 
To formulate the power-based model in the state space representation, the b matrix 
described in Equation(2.14) will change to: 
*
6
0
0
0
0
0
( )
b
L x t

 
 
 
 
 
 
 
            
(3.8) 
Note that the rest of the system described by Equations(2.11), (2.12) and (2.13) will not 
be changing. 
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Table 3.1: Model Parameters for the Current-Based Model 
Parameters Value Physiological Meaning 
  13,600 Density of a reference fluid (kg/m3) 
g  9.8 Acceleration of gravity (m/s2) 

 100% Pump efficiency  
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3.2. Simulation Results 
 In order to observe how the pump speed signal changes over its range of operation, the 
6
th
 order power-based model is excited with a linearly increasing values of electric pump power 
according to the following expression: 
( ) 0.6 0.12 ,0 60EP t t t          (3.9) 
The variable parameters in the model are set at heart rate of 60 bpm; SR =1 mmHg٠s/ml 
(indicating a normal activity level); and maxE =1 mmHg/ml (indicating a mild heart failure 
condition). Such pump motor power profile allows the pump to operate first in the normal 
operation range and then, at t =43 s, it operates during suction. 
Figure 3.1 illustrates the variations of the pump speed as the pump electric power 
increases. First note that the linear increase of the pump electric power is accompanied by 
nonlinear increase in the mean value of the rotational pump speed. It is important to note that this 
nonlinear relation between the speed and the power is true within the normal operation region of 
the pump speed. Once the pump operates in the suction region, the signature of the pump speed 
signal is changed. 
Second, the pump speed has a superposed oscillatory component that has the same 
pulsatility of the heart ( HR =60 bpm). This shows how the pulstaility of the heart affect the 
performance of the pump. This phenomenon has recently been observed in in-vivo data obtained 
through clinical studies [38]. This is the first time a mathematical model is capable of 
reproducing such phenomenon. This represents a breakthrough in accurately modeling this 
complex bio-mechanical system. 
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Third, the amplitude of the oscillatory component of the pump speed signal decreases as 
the power increase. This happens because when the pump speed increases, it withdraws blood 
from the ventricle faster (i.e. the rate of unloading increases).  As the blood volume inside the 
ventricle decreases, the left ventricle pressure also decreases. Hence, the effect of the heart on the 
pump performance diminishes. The amplitude of the signal exhibits a sudden increase (in this 
example at t =43 s.) at the start of suction. It can be from Figure 3.3 which shows the pump flow 
that suction behavior also is observed at t =43 s. Such behavior is in accordance to what was 
reported in literature either in simulation or in in-vivo data [8]-[10], [39]-[42]. Furthermore, 
when the pump is operating during suction, a noticeable change in the characteristics and the 
shape of the pump speed signal can be observed. These changes are seen clearly in Figure 3.2 in 
which details of the results of Figure 3.1 are shown over two 5-second intervals, from 10 15t 
(normal) and 45 50t  (suction). Such distinction in the signal shape has been used in the 
determination of the onset of suction using Lagrangian support vector machine method [43].  
Next we need to study the effect varying maxE  
on the hemodynamic of the patient and the 
pump performance. For this reason we simulated with four different value of maxE to represent 
varying degrees of the severity of the cardiovascular disease. Starting from maxE =1.0 mmHg/ml 
to represent a sick heart, and gradually decreasing it till max 0.25E  mmHg/ml to represent a 
critically sick heart. The pump motor power is kept constant ( ( )EP t =2.16 W.) for each time the 
model is simulated with different maxE . Figure 3.4 shows that as maxE decreases, the pressure 
inside the left ventricle ( )LVP t  decreases, specifically during the contraction and ejection phases 
of the cardiac cycle. This is expected since the heart does most of its work during these two 
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phases. In addition, Figure 3.5 shows that the pump speed signal, at a constant
EP , is greatly 
affected by the value of maxE . When maxE is set at 1 mmHg/ml, the amplitude of the pump speed 
signal is 680 rpm (i.e. ~5.59% of its mean value). When maxE is set at 0.25 mmHg/ml, however, 
the amplitude of the pump speed signal is reduced to 142 rpm (i.e. 1.17% of its mean value). 
Such phenomenon can be used in a less invasive approach to estimate maxE for LVAD patients. 
The amplitude and the change percentage are calculated according to these Equations: 
 
1
Amplitude max( ) min( )
2
          (3.10) 
Amplitude
Percentage of Change
mean( )
        (3.11) 
Constant monitoring for maxE can help physicians in diagnostics and therapeutic decisions 
on heart protection and eventual weaning strategies for LVAD patients [44].Using the pump 
speed and pump electric power signals can help in estimating maxE without the need to use 
Equation (1.15) which requires access to ( )LVP t and ( )LVV t , both signals require invasive 
measurements. Algorithms to estimate maxE have been developed in [46]-[47], however such 
algorithms assumes a healthy heart or a patient with sick heart but no LVAD implanted. Other 
approaches developed contractility indices for the LVAD patients, instead of estimating maxE , to 
evaluate how good the ventricle can contract. One method used the pump flow and pump speed 
to develop its contractility index [48]. The pump flow needs to be measured using flow meter or 
to be estimated.  
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Fifth, Table 3.2 shows results that are compiled from Figure 3.4, Figure 3.5and Figure 3.6. 
These results show that for a critically sick heart (
maxE =0.25) the average speed of the pump is 
higher than that of the sick heart (
maxE =1.00), while the pump flow is lower when maxE =0.25. 
This means that, for the same constant pump electric power, the pump has to run faster and 
produce lower flow rate when 
maxE =0.25. 
It is also interesting to note that during systole the highest pump speed is for 
maxE =0.25, 
followed by maxE =0.50, maxE =0.75 and maxE =1.00, respectively. During diastole, however, this 
order is reversed and the highest pump speed is for maxE =1.00.  
In contrast the highest flow rate during systole is for maxE =1.00, followed by maxE =0.75, 
maxE =0.50 and maxE =0.25, respectively. During diastole, however, this order is reversed and the 
highest pump speed is for maxE =0.25. 
These differences between the four pump speed signals (and also the four pump flow 
signals) are noticeable during systole, while in diastole such differences are very small. The 
reason for these differences is clear when looking at Figure 3.4. The ( )LVP t signals for the 
different cases of maxE in the systole phase vary clearly. The higher the value of maxE , the greater 
the instantaneous values of ( )LVP t . This causes the dynamics of the pump and flow to be 
different according to the maxE value.   The ( )LVP t  during the diastole phase is almost the same 
for the four different cases of maxE . The diastole is the relaxation phase of the left ventricle 
during the cardiac cycle, hence the strength of the left ventricle (i.e maxE ) has little influence on 
the dynamics of the pump and the flow. 
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3.3. Summary 
In this chapter, we presented a combined model of the cardiovascular-LVAD system with 
the pump motor power as the control variable. This control variable was chosen over the pump 
speed because in reality the LVAD is controlled by the electric power delivered to the pump 
which, in turn, controls the pump speed. When the pump is controlled in terms of its speed, the 
actual implementation of any desired pump speed profile requires the solution of an inverse 
problem in order to determine the corresponding pump motor power that can yield that speed 
profile. Such inverse problem is difficult to solve because of the nonlinearity between the pump 
speed and the pump motor power, and the coupling effect between the ventricle and the pump. 
A relationship between the pump motor electric power and the pump speed is derived in 
this chapter. This relationship shows how the pump speed is affected by the pump flow. An 
interesting observation is also noted about how this model can help in the development of 
algorithms that can estimate maxE .  
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Figure 3.1: Pump speed signal as a function of time when the pump motor power is increased linearly 
 
 
 
Figure 3.2: Pump speed signal during normal operation (left), pump speed signal during suction (right) 
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Figure 3.3: Pump flow with the pump motor power increasing linearly  
 
 
 
Figure 3.4: Left ventricular pressure for different values of maxE and constant EP =2.16 W. 
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Figure 3.5: Pump speed for different values of maxE  and constant EP =2.16 W. 
 
 
Figure 3.6: Pump flow for different values of maxE  and constant ( )i t =2.16 W. 
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Table 3.2: Results when maxE is varied from 1.00 to 0.25, while EP is kept constant 
 max
E =1.00 maxE =0.75 maxE =0.50 maxE =0.25 
Average pump flow PQ
(ml/s) 
113.08 111.90 110.71 109.63 
Average systole PQ  
(ml/s) 
122.92 119.14 115.30 111.56 
Average diastole PQ  
(ml/s) 
106.01 106.70 107.43 108.25 
Average pump speed 
(rpm) 
12,057 12,106 12,159 12,213 
Average systole   
(rpm) 
11,552 11,725 11,913 12,107 
Average diastole   
(rpm) 
12,419 12,378 12,336 12,289 
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CHAPTER 4: A FEEDBACK CONTROLLER TO DELIVER 
PHYSIOLOGICAL DEMAND FOR LVAD PATIENTS 
In this chapter we develop a feedback controller that can help patients outfitted with an 
LVAD that is used as a destination therapy or bridge to transplant device. In both destination 
therapy and bridge to transplant the device is implanted for a longer period of time compared to 
the bridge to recovery treatments. Hence, the main objective of the controller is to provide the 
patient with blood flow as close as possible to that produced by a healthy heart. This allows the 
patient to return to a close to normal activity during the prolonged treatment period. This is 
accomplished by controlling the pump motor power to minimize the difference between the 
pump flow and the cardiac output of a healthy heart experiencing the same level of activity as the 
patient. Simulation results are presented to show the effectiveness of the feedback controller in 
matching the blood flow requirements of the patient. 
4.1. The Physiological Demand of LVAD Patients 
The physiological demand of LVAD patients is defined as the required blood flow that 
the body needs per minute. In a healthy heart, this is equal to the cardiac output as the heart can 
deliver blood to the rest of the body. For a heart failure patient, however, the heart is not strong 
enough to produce the cardiac output that can satisfy the physiological demand of the patient, so 
the LVAD is implanted to provide the patient with an increased blood flow. 
 For treatments that require long time period of LVAD support, the main focus should be 
on providing adequate support. Destination therapy and bridge to transplant fall under this 
category of treatments.  
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The problem of providing the adequate physiological demand for the LVAD patient is the 
fact that the level of activity of the patient is constantly changing. The LVAD pump controller 
needs to be able to increase or decrease the blood flow to match such changes. In addition the 
controller must be reliable and robust. 
Under current practice [49], physicians perform a ramped speed study on the patient, 
while monitoring key hemodynamic data, to determine a fixed speed setting for this patient. Any 
change in the controller parameters during the LVAD support is done by a physician or a 
clinician (i.e. open loop control techniques) during routine visits or when there are indications of 
inadequate support [49]. As mentioned, the need to adjust the LVAD support is due to the 
different levels of activities experienced by the patients and their emotional changes too [50], 
[51]. These changes exhibited by a wide variation of the systemic vascular resistance of the 
LVAD patient which is represented by SR  in the mathematical model presented in chapter three 
[52]-[54]. 
Table 4.1 shows simulation results from the model to highlight the issues with the 
constant LVAD support. The first column shows the cardiac outputs produced by a healthy heart 
(i.e. max
E
=2.00 mmHg) for different levels of activities. These values are used as a reference for 
what the physiological demand of heart failure patient that is experiencing a similar level of 
activity. Second column in the table shows the cardiac outputs of a patient with a mild heart 
failure with no LVAD support. The third column shows the aortic flow (i.e. the sum of the pump 
flow and the flow pumped through the aortic valve by the native heart) of a mild heart failure 
patient with constant LVAD support. Constant LVAD support means that the pump motor power 
doesn’t change during the entire support time. In this case the pump motor power is set at 1W. 
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By comparing the values in the healthy heart case and the constant LVAD support case, it is 
obvious that while the constant LVAD support matches the cardiac output of a healthy heart in 
the case of moderate activity level ( 75, 1.0SHR R  ), it doesn’t match the cardiac output in the 
cases of very active and inactive levels. In the case of very active patient it is seen that the 
constant level of support provides 1.29 l/min less than the physiological demand of the patient. 
In the case of the inactive level the constant LVAD support provides 0.39 l/min more than the 
physiological demand, which could be negatively impacting the heart by providing more blood 
than needed and risking the occurrence of suction events. In addition, this means that the 
controller is drawing more power from the LVAD batteries than what is actually needed. 
Comparing the values in the first and second column shows that the cardiac output of a 
mild heart failure patient with no LVAD support provides about 25% less blood flow of that of 
the healthy heart. The objective of the LVAD is to compensate for this 25% deficit, but with the 
constant LVAD support, however, this is not possible. 
Table 4.1 offers an interesting observation about the aortic flows of the constant LVAD 
support. When the pump controller parameters are kept constant, one would expect that the flow 
remains constant, but it is shown that this is not true as the flow increases with the increased 
level of activity. This is because the cardiovascular system and the pump are coupled systems 
that affect each other. As the level of activity increases the heart rate increase provides more 
blood available to the pump, additionally, the systemic vascular resistance decreases making the 
blood flows faster in the circulation. 
This phenomenon has been observed, both in simulation and in-vivo data, that for 
constant pump motor power,  the mean pump flow increases when the activity level of the 
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patient increases, and vice versa [58]. Figure 4.1 and Figure 4.2 are obtained from simulation and 
they show plots of both pump speed and pump flow spontaneously reacting to changes in the 
systemic vascular resistance without any changes in the controller parameters. For example, the 
pump motor power is set at 2.16W. and 
maxE =1.0 mmHg/ml, the mean pump flow is measured 
for three different values of 
SR . As mentioned earlier the lower the value of  SR indicating an 
increase in the activity level, the higher the mean pump flow, as shown in Figure 4.2. This shows 
that the cardiovascular system combined with the LAVD pump can sense the change in the 
patient’s level of activity and then react accordingly. It should be mentioned though that when 
the blood flow increases in a respond to an increased level of activity, such increase is not 
sufficient to match the physiological demand. Similarly, when the blood flow decreases when the 
activity level decreases, such decrease doesn’t get low enough to match the demand (i.e. the 
pump is providing more blood than needed by the body).  
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Table 4.1: Aortic flow comparison between aortic flow of a healthy heart, mild heart failure with no support 
and mild heart failure with constant LVAD support, for different activity levels 
 
Aortic flow  
Healthy heart 
maxE =2.00 
mmHg 
No LVAD support
maxE =1.00 mmHg 
Constant LVAD 
Support
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mmHg 
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Very active 
120bpm
0.5 mmHg.s/mlS
HR
R

  
9.25 l/min 6.86 l/min 7.96 l/min 
    
Moderately active
75bpm
1.0mmHg.s/mlS
HR
R

  
5.10 l/min 3.80 l/min 5.18 l/min 
    
Inactive
60bpm
1.2mmHg.s/mlS
HR
R

  
4.32 l/min 3.17 l/min 4.71 l/min 
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Figure 4.1: Pump speed signal for different SR , with no change to the controller parameters 
 
 
 
Figure 4.2: Pump flow signal for different SR , with no change to the controller parameters 
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4.2. Development of the Feedback Controller 
The development of a feedback controller for the LVAD is an important challenge facing 
the increased use of such devices. Such variations in blood flow demand require a feedback 
controller that can automatically change the pump motor power to meet the body requirements 
for cardiac output and keep the mean arterial pressure within the normal limits [8]. Ideally, the 
development of a feedback controller requires the availability of real-time measurements of the 
hemodynamic of the patient. These measurements, however, are generally difficult to obtain 
because the placement of pressure or flow sensors, for long-term application in the human heart, 
is not possible under the current technology [55]. The pump flow (
PQ ) is a suitable feedback 
variable since it requires a flow-meter installed at one of the pump cannulae. Figure 4.3shows a 
schematic of a controller that uses pump flow measurements to control the pump speed using the 
pump motor power. 
This fact is used in estimating the level of activity of the patient by estimating SR . This is 
accomplished by minimizing an error signal which is a measure of the difference between the 
actual pump flow measurements of the patient and the pump flow calculated based on the 
estimated SR . Once SR is estimated, the cardiac output of a healthy heart experiencing the same 
level of activity is determined by using the 5
th
 order model of the healthy heart. This is followed 
by the manipulation of the control variable (i.e. pump motor power) to achieve the desired pump 
flow. 
The feedback controller shown in Figure 4.3 consists of four stages:  
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The first stage, which is labeled “detect change in pump flow”, is used to detect changes 
in the activity level of the patient and prompt the controller to react to such changes. As 
mentioned a change in the mean pump flow signal without the pump motor power changing is an 
indication of a variation in the activity level of the patient. In this stage the pump flow signal is 
measured and the average ( )PmQ is calculated during each cardiac cycle.  
The second stage, labeled “Estimate the level of activity ( )SR using the 6
th
 order model” 
involves adjusting the numerical value of SR in the 6
th
 order model through a recursive approach 
until the resulting mean pump flow from the model matches the actual mean pump flow of the 
patient. This is accomplished by minimizing the square of the difference between the measured 
and calculated mean pump flows as seen in Equation(4.1). 
 
2
minimize ( ) ( ,S Pm P S PoJ R Q Q R P        (4.1) 
Where PQ is the mean pump flow calculated by simulating the 6
th
 order patient-specific 
model. The pump motor power used in the model ( )PoP should be the same as the actual power 
supplied to the LVAD pump because the model must simulate the current state of the patient 
while changing SR through a recursive algorithm to minimize the function in Equation(4.1). 
During the third stage, labeled “Calculate physiological demand for the estimated SR ”, 
the physiological demand or required mean pump flow under the current activity level is 
determined by imposing the value of SR  estimated during the previous stage into the 5
th
 order 
model with 
max 2 mmHg/mlE   to represent a healthy heart. This is done since the overall 
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objective of the controller is to determine the actual output of a healthy heart under the current 
level of activity, characterized by the estimated
SR , and try to match it with the LVAD output.  
During the fourth stage, labeled “Update Pump Motor Power”, the pump motor power  
will be adjusted until the mean pump flow approaches the physiological demand for the current 
level of activity calculated in the previous stage. Again, this is accomplished by minimizing the 
square of the difference between the physiological demand and the adjusted mean pump flow as 
seen in Equation(4.2).  
 
2
ˆminimize ( ) ( , )E P S Ef P CO Q R P        (4.2) 
Where CO is the required blood flow for the patient, ˆSR is the estimated systemic 
vascular resistance of the patient and EP is changing through recursive algorithm to minimize the 
function in Equation(4.2). The EP value that results in minimizing such function is the control 
signal that is sent to the pump to adjust its speed. 
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Figure 4.3:Block diagram for the feedback controller 
 
 
 
 
 
 
 
 
 
  
Calculate 
the demand 
Detect 
Changes in 
PmQ  
Estimate 
Level of 
activity ˆ
SR  
Update 
Pump 
Motor 
Power 
TQ
Systemic 
circulation 
Pump 
LVAD 
PQ
( )EP t
Feedback Controller 
Pump flow measurements 
Sensor to measure the pump flow 
59 
 
4.3. Simulation results 
In this section we test the feedback controlled explained in the previous section. Figure 4.1 
 shows a simulation example of a patient initially at rest who then becomes more physically 
active. This simulation is modeled by a change in 
SR from 1 mmHg.s/ml to 0.5 mmHg.s/ml. at t
=4s.  
The Fibonacci search algorithm is chosen to minimize the objective function in 
Equations(4.1) and (4.2), because of its inherent advantage of having a predefined number of 
iteration before the algorithm arrives at a solution. The number of iterations depends on the 
tolerance specified by the system [59]. 
The Fibonacci search was then used to estimate this change in SR . The number of 
iterations required to arrive at a converged solution was predetermined based on both the 
possible range of SR  and the tolerance required; the former is assumed to be between 0.4 and 1.4 
mmHg.s/ml while the latter was established as 0.01 mmHg.s/ml. Hence: 
11
1.4 0.4
100 144 100 11
0.01
nF F n
 
       
 
     (4.3)  
Here, the number of required iterations, n , is determined as the n th Fibonacci number 
larger than the search range divided by the tolerance. In this case, the 11
th
 Fibonacci number 
satisfies this criterion.  
Using the 6
th
 order model the SR will be estimated in an iterative manner. The search 
bracket is narrowed down at every iteration step until the convergence criterion is met after the 
n h iteration. This process is shown in Figure 4.5. 
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 Although the search interval was originally set for values of 
SR  between 0.4 and 1.4 
mmHg.s/ml, prior knowledge of the dynamics of the system allows us to start from a narrower 
interval. That is, it could have been assumed a priori that the increase in mean pump flow signal 
was evidence of a decrease in 
SR  and therefore start with a bracket between 0.4 and 1.0 
mmHg.s/ml instead, for example, leading to a smaller number of required iterations. The value of 
SR is estimated at 0.5 (Which is a correct estimation since this is the value we used in our 
simulation). This value will be taken and substituted in the 5
th
 order model and the CO will be 
calculated over one cardiac cycle.  
 For the case being implemented herein, the physiological demand CO  was found 
to be 148.9 ml/s, larger than the current mean pump flow of 115.3 ml/s achieved by a pump 
motor power of 1.2W. Therefore, an increase of the pump motor power is necessary to achieve 
the goal of meeting the physiological demand. The initial bracket for the pump motor power was 
then established between 1.2W and 7.8W. Figure 4.6 shows the evolution of the EP  bracket 
throughout the Fibonacci search algorithm. 
The research presented in this chapter has limitations that should be mentioned. The 
simulation results are based on a constant heart rate during all different cases of activity level. 
This was done to observe how the pump flow changes when only the systemic vascular 
resistance changes. It should be noted that the changes in the systemic vascular resistance, in 
most cases, is associated with a change in the heart rate.     
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Figure 4.4: Pump Flow signal as SR Changes from 1 to 0.5 mmHg.s/ml 
 
 
 
Figure 4.5: Lower and Upper Brackets of the Fibonacci Search to Estimate SR  
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Figure 4.6: Lower and Upper Brackets of the Fibonacci Search to Estimate EP  
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4.4. Summary 
In this chapter, we developed a feedback controller that can be implemented in LVAD 
devices used in destination therapy and bridge to transplant. The objective of the controller is to 
provide the blood flow for the heart failure patient that is equivalent to the cardiac output of a 
healthy heart experiencing the same level of activity. The controller achieves this by estimating 
SR which is a representation of the activity level. The controller uses the 5
th
 order model to 
calculate the cardiac output of a healthy heart at the same level activity of the patient and set it as 
the targeted blood flow rate. By adjusting the pump motor power, the controller can achieve the 
targeted blood flow rate. A simulation example is used to illustrate the four stages performed by 
the controller. 
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CHAPTER 5: ENGINEERING ANALYSIS OF THE AORTIC VALVE 
DYNAMICS IN PATIENTS WITH LEFT VENTRICULAR ASSIST 
DEVICES 
The objective of this chapter is to observe the effect of the permanent closure of the valve 
on the hemodynamic waveforms of the LVAD patient, as well as the effect of the pump power 
on the dynamics of the valve. The chapter starts by explaining how the mathematical model that 
was presented in Chapter Three will be used to collect the data. This is followed by an analysis 
of the effect of the permanent closure of the aortic valve on the hemodynamic conditions of the 
patient. The simulation results also show the effect of the pump flow on the aortic valve. Finally, 
a summary is presented.  
5.1. Method for data collection 
The second generation pumps for the LVAD creates a continuous flow of blood in the 
aorta opposed to the pulstaile flow that is natively created by the human heart. Naturally, the 
pulstaile flow happens due to the aortic valve opening during the ejection phase and then closing 
for the remainder of the cardiac cycle. When the LVAD is present, however, the ejection phase 
time is shortened (i.e. aortic valve opens for a shorter duration), or in some cases is completely 
skipped (i.e. aortic valve closes during the entire cycle) when the pump is operating at a higher 
setting, the latter case is referred to as permanent closure of the aortic valve. This change in the 
flow pattern causes changes in the hemodynamic conditions of the patient and affects the pump 
performance. The permanent closure of the valve happens because the pump is unloading the left 
ventricle fast enough that the pressure inside the ventricle is not sufficient to force the blood to 
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be pumped through the aortic valve. Such permanent closure can further lead to undesirable 
changes in the hemodynamic conditions of the patient.  
The mathematical model is used to study the effect of the aortic valve dynamics on the 
hemodynamic of the LVAD patient and on the pump performance characteristics.  We excited 
the model with different values of the control variable
EP so that the effect of the pump on the 
aortic valve can be observed over a wide range of pump operation. It is imperative that this range 
includes the critical value of EP , henceforth denoted by
c
EP , at which the permanent closure of the 
aortic valve first occurs. As explained in chapter three, there is a complex relation between the 
pump motor power and its rotational speed, so we will define the critical speed c as the pump 
speed when the pump motor is supplied with the critical pump power cEP . 
In order to detect the permanent closure of the aortic, we observed the diode AD , in 
Figure 2.3, which represents the aortic valve.  An aortic valve that is operating normally is 
simulated by  AD  being open (i.e., short circuit) during the ejection portion of each cardiac cycle. 
Permanent closure of the valve happens when AD closes (i.e., becomes open circuit) and remains 
closed for the entire duration of the cardiac cycle. The case when the permanent closure occurs 
translates to zero flow through AR , meaning there is no flow through the aortic valve, and that 
flow through the pump is equal to the total flow through the aorta (i.e. 5 6( ) ( )x t x t ). 
The complexity in this analysis arises from the fact that the critical pump power cEP  
depends on two physiological factors: (i) the severity of the heart failure, and (ii) the activity 
level of the patient. To cover a wide range of these factors, we simulated nine different cases 
corresponding to combinations of three different levels of heart failure (represented by three 
66 
 
different values of 
maxE ) and three different levels of patient activity (represented by three 
different values of 
SR with corresponding values of heart rate, HR ) [60].  These cases are 
summarized in Table 5.1 
 
  
Table 5.1: Nine different cases representing combination of three levels of heart failure and three levels of 
patient activity. 
 
Level of Heart Failure 
maxE =1.00 mmHg maxE =0.75mmHg maxE =0.50mmHg 
L
ev
el
 o
f 
p
h
y
si
ca
l 
A
ct
iv
it
y
 
120 bpm
0.5 mmHg.s/mlS
HR
R

  
Mild Heart Failure 
Very Active 
Moderate Heart 
Failure 
Very Active 
Sever Heart Failure 
Very Active 
    
75 bpm
1.0 mmHg.s/mlS
HR
R

  
Mild Heart Failure 
Moderately  Active 
Moderate Heart 
Failure 
Moderately  Active 
Sever Heart Failure 
Moderately  Active 
    
60 bpm
1.2 mmHg.s/mlS
HR
R

  
Mild Heart Failure 
Inactive 
Moderate Heart 
Failure 
Inactive 
Sever Heart Failure 
Inactive 
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5.2. Simulation results 
The nine different cases described in Table 5.1 have been simulated using our model for a 
range of 
EP starting at 0.1W and ending at 1.6W. Before summarizing the overall results, we will 
first describe in detail the results that correspond to only one representative case: a patient with 
mild heart failure and with a moderate level of activity (i.e. 
maxE =1, HR =75 and SR =1.0).  We 
will then illustrate graphically the general results encompassing all other eight cases to show the 
effects of the aortic valve dynamics as the severity of the heart failure as well as the activity level 
of the patient vary as described in Table 5.1 [60]. 
   Figure 5.1 shows a plot of the minimum, maximum (i.e. peak) and mean values of the 
blood flow signal through the aortic valve as a function of EP .  It is clear from this plot that the 
aortic valve closure occurs at the critical value of 0.8cEP W and a corresponding critical speed
9,052c  rpm. Note that the minimum values of the blood flow through the aortic valve are 
small negative values when pump power is below c
EP . This small reverse flow in the aortic valve 
is due to the effect of the aortic compliance (denoted by AC in Figure 2.3). Physiologically this is 
due to the adverse pressure gradient that is developed as the aortic flow begins to decelerate 
rapidly after reaching its peak which affects the low momentum fluid near the wall of the aorta 
causing reverse flow in the sinus region [61]. The plot in Figure 5.1 also shows that as EP is 
increased starting at 0.1W, the mean value of blood flow through the aortic valve decreases, as 
expected, but the maximum value of the blood flow also decreases but at a very sharp and much 
faster rate. This happens because as pump power is increased, the pump speed will also increase 
resulting in a higher pressure difference between the left ventricle and aorta, which causes more 
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blood to flow through the pump rather than through the aortic valve. This phenomenon is more 
evident in Figure 5.2 which shows a plot of the pump flow signal as a function of
EP  . While all 
values (max, mean and min) of the pump flow increase, as expected, with increasing values of
EP , 
the maximum value seems to exhibit a breakpoint at the critical power 0.8cEP W  by remaining 
constant with zero slope as 
EP is increased beyond
c
EP .  This breakpoint in the slope of the 
maximum values of the pump flow occurs exactly when the aortic valve closes for the entire 
cardiac cycle and continues to be closed as EP  is increased.  
Figure 5.3 shows the left ventricle pressure as a function of EP . It is important to notice 
that the minimum values of this signal almost stay constant as EP  is increased, even after 
c
EP  is 
reached. This is due to the fact that the minimum value of the left ventricle pressure happens 
during the filling phase, which is not greatly affected by the aortic valve dynamics. The 
maximum values, on the other hand, only stay constant before cEP ; once this critical value is 
reached the maximum value is decreasing at a very sharp rate. The maximum value happens 
during the rapid ejection of blood out of the aortic valve (i.e. early in the ejection phase). This 
means that as long as the aortic valve is opening during the cardiac cycle, there is enough blood 
volume in the ventricle to reach certain pressure that can force the aortic valve to open. Once cEP
is exceeded, the maximum value starts to decrease due to the decrease in the blood volume inside 
the ventricle at the end of the filling (diastolic) phase (LVEDV). It is interesting to see the mean 
values are decreasing before cEP  is reached, while the maximum and minimum values stay 
almost the same. The reason for that decrease is the shorter duration of the aortic valve opening 
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(more details on aortic valve opening duration in the next chapter), which leads to reaching the 
minimum value faster as the EP increases. Once 
c
EP  is reached, the mean values decrease at a 
higher rate simply due to the aortic valve closure and the ejection phase not occurring. The mean 
values decreases as the maximum value decreases and 
EP increases. 
Figure 5.4 shows a plot of aortic pressure as a function of EP .  Prior to
c
EP , the maximum 
value of the aortic pressure signal is almost constant. The maximum values happen during the 
reduced ejection phase (i.e. later in the ejection phase). On the other hand, both the minimum and 
mean values are increasing as the value of EP increases. The minimum values increase because 
as the EP  increases, the duration of the aortic valve opening decreases. This leads to less blood 
flow through the valve and more blood flowing at an increasingly higher rate through the pump. 
Hence, the more blood volume in the aorta during diastole, the higher the minimum values of the 
aortic pressure signal.  After exceeding the value of 
E
cP  , the three values (i.e. maximum, 
minimum and mean) are increasing in a higher rate. Since the aortic valve is no longer opening, 
the pressure in the aorta is increasing as the unloading rate is increasing. If this increase 
continues, the aortic pressure will reach a certain level when it doesn’t have any pulsatility (i.e. 
the signal will be flat line).  
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Figure 5.1: Change of aortic valve flow rate with ump motor power 
 
Figure 5.2.  Pump Flow as a function of pump motor power 
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Figure 5.3.  Left ventricle pressure as a function of pump power 
 
  
 
Figure 5.4.  Aortic pressure as a function of pump power 
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Figure 5.5 through Figure 5.12 show the same waveforms for the other eight cases that 
were listed in Table 5.1. It is clear that all these waveforms exhibit the same characteristics as the 
ones listed in the case we discussed in detail previously (i.e. Mild heart failure, moderately active 
patient). As expected we see that the case of a mild heart failure patient with high level of 
activity (i.e. maxE =1, HR =120 and SR =0.5) has a higher value of E
cP , while the case of severe 
heart failure and low level of activity (i.e. maxE =0.5, HR =60 and SR =1.2) has the lower value of
E
cP . 
Since 
c
EP  and 
c are related by a complex nonlinear expression (see Equation(3.7)), the 
values of  
c
EP  and corresponding 
c  for the nine cases in Table 5.1 are given in Table 5.2.   The 
relationship between 
c
EP  and  
c is quite interesting but not surprising.  First, increasing the 
power to the LVAD does not always necessarily mean increasing the speed.  As is clear from 
Equation(3.7), the speed is also dependent on the rate of blood flow through the pump, which 
may have a compensating effect on the speed (i.e., decreasing it even if EP  is increasing).  
Second, for all three levels of activity, the weaker the heart, the lower the speed at which the 
aortic valve shuts down, as expected.  For example, for an inactive patient, the aortic valve shuts 
down when the speed reaches 7433 rpm if the heart is severely sick, but can hold off until the 
speed reaches 9168 rpm if the heart is mildly sick.  On the other hand, for a given level of heart 
failure, the lowest speed at which the aortic valve shuts down seems to vary with the level of 
activity.   For a patient with mild heart failure, the aortic valve shuts down first when the activity 
level is moderate at 9052 rpm, but for a patient with moderate or severe heart failure, the valve 
shuts down first at 8403 rpm and 7433 rpm, respectively, when the patient is inactive. What this 
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essentially means is that for a given state of heart failure, if the level of activity of the patient is 
continuously changing, the pump should be operated at control values of power and speed that 
do not go above the lowest values that result in shutting down of the aortic valve.  Finally, it is 
interesting to note that the results in Table 5.2 are minimally affected by the pump parameters in 
the model, suggesting that the above observations are valid for a wide range of LVADs whose 
pumps can be modeled as described in Chapter Three.  Our analysis indicates that the critical 
pump speeds remain within ±0.7% of the nominal values shown in Table 5.2 when the pump 
parameters 
PR and PL are changed by ±10% from their nominal values as shown in Table 2.1. 
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Figure 5.5: Waveforms for the case of inactive patient with mild heart failure. (a) Aortic valve flow, (b) pump 
flow, (c) Left ventricle pressure and (d) Aortic pressure. 
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Figure 5.6: Waveforms for the case of very active patient with mild heart failure. (a) Aortic valve flow, (b) 
pump flow, (c) Left ventricle pressure and (d) Aortic pressure. 
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Figure 5.7: Waveforms for the case of inactive patient with moderate heart failure. (a) Aortic valve flow, (b) 
pump flow, (c) Left ventricle pressure and (d) Aortic pressure. 
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Figure 5.8: Waveforms for the case of moderately active patient with moderate heart failure. (a) Aortic valve 
flow, (b) pump flow, (c) Left ventricle pressure and (d) Aortic pressure. 
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Figure 5.9: Waveforms for the case of very active patient with moderate heart failure. (a) Aortic valve flow, 
(b) pump flow, (c) Left ventricle pressure and (d) Aortic pressure. 
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Figure 5.10: Waveforms for the case of inactive patient with severe heart failure. (a) Aortic valve flow, (b) 
pump flow, (c) Left ventricle pressure and (d) Aortic pressure. 
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Figure 5.11: Waveforms for the case of moderately active patient with severe heart failure. (a) Aortic valve 
flow, (b) pump flow, (c) Left ventricle pressure and (d) Aortic pressure. 
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Figure 5.12: Waveforms for the case of very active patient with severe heart failure. (a) Aortic valve flow, (b) 
pump flow, (c) Left ventricle pressure and (d) Aortic pressure. 
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Table 5.2: Critical pump power (
E
cP ) values of the nine different cases. 
 
Level of Heart Failure 
maxE =1.00mmHg maxE =0.75mmHg maxE =0.50mmHg 
L
ev
el
 o
f 
p
h
y
si
ca
l 
A
ct
iv
it
y
 
120 bpm
0.5 mmHg.s/mlS
HR
R

  
1.6
E
cP W  
9,454c rpm   
1.2
E
cP W  
8,825c rpm   
0.7
E
cP W  
7,732c rpm   
    
75bpm
1.0mmHg.s/mlS
HR
R

  
0.8
E
cP W  
9,052c rpm   
0.6
E
cP W  
8,460c rpm   
0.4
E
cP W  
7,694c rpm   
    
60bpm
1.2mmHg.s/mlS
HR
R

  
0.7
E
cP W  
9,168c rpm   
0.5
E
cP W  
8,403c rpm   
0.3
E
cP W  
7,433c rpm   
 
5.3. Summary 
In this chapter we introduced the importance of studying the aortic valve dynamics effect 
on the hemodynamic of the patient, and how the pump power affects the valve opening during 
the cardiac cycle. We used our mathematical model to run nine different simulations that covers 
a variety of patient cases to observe such changes when the aortic valve is working properly (i.e. 
opening and closing every cardiac cycle) and when it is in the permanent closure state. The 
simulation results are then presented and they show consistent waveform patterns among all the 
nine cases. The following chapter will continue investigating the aortic valve dynamics 
specifically on bridge to recovery patients.  
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CHAPTER 6: AORTIC VLAVE DYNAMICS IN BRIDGE TO RECOVERY 
TREATMENTS 
In this chapter, we explain the necessity of studying the aortic valve dynamics during the 
LVAD support for bridge to recovery treatment. By using the mathematical model, we examine 
the aortic valve performance prior to its permanent closure for different activity levels of the 
patient and severity of heart failure. Additionally, LVAD power and speed control parameters 
that yield a given percentage of the cardiac cycle during which the aortic valve remains open are 
examined indicating that the severity of the heart failure is a very important factor in deciding the 
appropriateness of the LVAD as a bridge to recovery treatment. Then preliminary results are 
given to show the characteristics of the systemic circulation flow signal when the aortic valve is 
open and closed. Finally, a summary is presented. 
6.1. Aortic valve permanent closure problems 
The bridge to recovery treatment differs from the other two types of treatments in the 
sense that the native heart of the patient will have to completely support the blood flow demand 
on its own after the device is removed. In the bridge to transplant and the destination therapy this 
is not the case. In the former type the device supports the patient until the transplant is performed 
and the patient has a new heart, in the latter type the device is implanted permanently to support 
the patient with no plans for removal. 
Bridge to recovery is a very critical use of the LVAD which was introduced in recent 
years [62],[63], and there are ongoing research activities to fully understand how the LVAD 
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affects the native heart of the patient. The aortic valve dynamics is an important assessment tool 
for indication of heart recovery and keeping normal operation of the valve can help avoiding 
incidents that can delay or prevent recovery.  
Normal operation of the valve essentially means the opening and closing of the valve 
every cardiac cycle. The opening of the aortic valve is the event that starts the ejection phase. 
The closing of the valve marks the end of the ejection phase and the beginning of the relaxation 
phase (as discussed in chapter 1). When the LVAD pump is implanted, however, it disturbs this 
cycle by shortening the ejection phase due to the pump rapidly unloading blood from the 
ventricle. As explained in chapter 5, with the increased pump motor power, the aortic valve 
closes for the entire cardiac cycle, this is known as the permanent closure.  
The permanent closure of the aortic valve of a bridge to recovery patient may cause 
numerous complications such as: 
1- Changes in the hemodynamic conditions of the patient: The changes in the 
hemodynamic conditions of the LVAD patient can be attributed to the decreased 
pulsatility that is associated with the aortic valve permanent closure. This decrease in 
pulsatility can be seen in the pressure and the flow waveforms of LVAD patients 
when the valve is closed (Shown in Section 5.2). As the pump speed increases, the 
pulsatility decreases due to the higher rate of unloading blood from the ventricle. 
When the aortic valve experience permanent closure, decreased pulsatility still exists 
mainly because the contractions of the left ventricle. This low pulsatility can lead to 
aortic insufficiency and other long term vascular complications [64]. 
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2- Aortic valve stenosis: It occurs to about 88% of LVAD patients [65]. Aortic stenosis 
is a narrowing of the aortic valve opening which can lead to a restricted blood flow 
from the left ventricle to the aorta. Figure 6.1 shows the differences between healthy 
aortic valve and aortic valve with stenosis, both during open and closed states. In the 
case of the aortic valve stenosis, it can be seen that the valve is not fully open in the 
“open state”, and it is partially closed in the “closed state”. This is a critical condition 
that needs to be avoided, since after the removal of the LVAD (as in bridge to 
recovery treatments) it is very important to have a functioning valve for the heart to 
continue supporting the patient’s blood flow demand on its own.  
3- Stagnation of blood flow and thrombus formation: The stagnation of flow increases 
the possibility of thrombus formation [67]in the aortic root and this raises the concern 
because the proximity of where the coronary arteries are located. Figure 6.2 shows 
the two main coronary arteries starting from a point near the aortic vlave. The 
coronary arteries are intended to feed the heart muscle with oxygenated blood from 
the negative flow in the aorta. The thrombus formation on the closed aortic valve will 
create coronary occlusion preventing blood to flow back through the coronary. This 
occlusion further weakens the heart muscle and increases the risk of fatal events such 
as cardiac arrest.   
 
For such reasons, the aortic valve opening during every cycle is important to avoid these 
events. The frequent opening of the valve will maintain pulsatility in the aortic flow which will 
resemble that of a healthy heart, albeit the pulse magnitude will still be lower in the case of the 
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LVAD patient. In addition, the regular opening of the aortic valve can keep the anatomical 
structure of the valve preserved; hence, avoiding the aortic valve fusion and aortic valve stenosis. 
Finally, to avoid the risks of thrombus formation on the coronary, the flow of blood through the 
opened aortic valve can wash out the thrombus regularly. This can clear the way for the coronary 
arteries to get the oxygenated blood intended to feed the heart muscle [68]. 
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Figure 6.1: Aortic Valve Stenosis (source: www.medindia.net) 
  
 
 
Figure 6.2: Coronary Circulation (source: www.wikipedia.com) 
 
  
Aortic Valve 
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6.2. Aortic valve performance  
In the previous chapter, we defined the pump motor power level at which the aortic valve 
starts experiencing the permanent closure. In this chapter, however, the research is extended to 
look at the performance of the aortic valve prior to the time when it closes permanently. This is 
an important factor that needs to be examined in bridge to recovery treatments. It is well known 
that for a healthy heart, a normal aortic valve remains open during about 30% of the cardiac 
cycle while blood is ejected through the valve to the aorta [69].  In bridge to recovery LVAD 
treatment, clearly the aortic valve does not instantaneously switch from normal operation (i.e. 
being open for a portion of the cardiac cycle) to complete closure.  One would expect that as the 
power level increase, the duration when the aortic valve remains open during a cardiac cycle will 
gradually decrease until permanent closure occurs at the critical values.  The nine different cases 
used in chapter 5, and described in Table 5.1, were used to obtain the percentage of the aortic 
valve duration before its permanent closure. Figure 6.3-Figure 6.5 show plots of the percentage 
of the cardiac cycle during which the aortic valve remains open for the mild, moderate and 
severe heart conditions respectively plotted against the pump power.  Each of these figures 
includes the three different cases of the activity level of the patient. It is interesting to note that, 
as expected, for an LVAD used as a bridge to recovery the range of flexibility in the control 
variable is widest when the heart failure condition is mildest (as in Figure 6.3).  In fact, for a very 
active patient with mild heart failure, the valve remains active - being open during about 10% of 
the cardiac cycle - even when EP reaches a value of 1.5W.  On the other hand, when the 
condition of the patient is severe (as in Figure 6.5) it is extremely difficult to control the power 
delivered to the LVAD in such a way as to keep the aortic valve operating properly.  The range 
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of control over which the valve remains operating properly is very narrow; lower than 0.3W, 
0.4W and 0.7W for inactive, moderately active and very active patient, respectively.  Comparing 
the three figures, it is important to note that regardless of the severity of heart failure, the more 
active the patient the larger cEP  will be.   
It is interesting to note that at very low pump motor power setting (i.e. 
EP =0.1W), the 
aortic valve opening duration percentage is roughly within 35%-40% of the cardiac cycle for the 
very active case, regardless of the heart failure severity. When the heart failure is severe, 
however, the rate of decrease in the opening percentage decreases rapidly, and it closes 
permanently at 0.7W. In the mild heart failure case, the decrease in the opening percentage of the 
valve is much slower than the other two cases, where the permanent closure occurs at 1.6W. This 
observation is also true for the cases of moderately active and Inactive, which their aortic valve 
opening percentages start at 20%-25% and 18%-23% of the cardiac cycle at EP =0.1W, 
respectively. 
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Figure 6.3.  Aortic valve opening time as a percentage of the cardiac cycle for mild heart failure 
 
 
Figure 6.4.  Aortic valve opening time as a percentage of the cardiac cycle for moderate heart failure 
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Figure 6.5.  Aortic valve opening time as a percentage of the cardiac cycle for severe heart failure 
 
  
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6
0
5
10
15
20
25
30
35
Pump Motor Power, P
E
 (Watts)
A
o
rt
ic
 v
a
lv
e
 o
p
e
n
in
g
 d
u
ra
ti
o
n
 (
%
)
 
 
very active
moderately active
inactive
92 
 
Generally speaking, it would be preferable to operate the LVAD at control values that result in a 
specified percentage of the cardiac cycle for the aortic valve to remain open. As an illustrative 
example, Table 6.1 shows the power requirements and resulting pump speeds that yield 
conditions where the aortic valve remains open for 15% of the duration of the corresponding 
cardiac cycle. The 15% was selected as a guideline because it represents half of the opening 
duration percentage of an aortic valve of a healthy individual. In addition, at 15% we can see 
clearly from the figures that the aortic valve will open during the cardiac cycle for each of the 
nine cases. Clearly all of these values are below the critical values given in Table 5.2 and may be 
used a guidelines for controlling the LVAD pump.   
One aspect of the results of interest is the level of cardiac support provided to the 
circulatory system in a bridge-to-recovery LVAD treatment.  Table 6.2 shows the total blood 
flow rate in the circulatory system when the LVAD is operated to keep the aortic valve open for 
15% of the duration of the corresponding cardiac cycle (i.e., using the control values shown in 
Table 6.1).  The total rate of blood that flows in the circulatory system of a healthy person (with 
maxE = 2) at the same three levels of activity defined in Table 5.1 are also shown in Table 6.2  
This table also shows the percentages for each of the nine blood flow rates with respect to the 
corresponding blood flow rate of a healthy heart. Note that in the case of mild heart failure, the 
total blood flow rate supplied to the circulatory system ranges between 87% and 91% of the 
blood flow rate required by a healthy heart. For the moderate heart failure case, this range is 
between 74% and 77%, and for the severe heart failure case, this range is between 56% and 59%.  
It is interesting to note that in each of these three cases, the range is very narrow (3 to 4%), 
indicating that the LVAD’s ability to meet the patient’s need for blood flow is not much affected 
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by the level of patient’s activity level.  However, for each level of activity, the LVAD’s ability to 
meet the patient’s blood need is highly dependent on the patient’s heart failure condition.  These 
percentages cover a much wider range (30 to 32%) depending on the patient’s heart condition. It 
is also important to note that in the severe heart failure case, the LVAD is only able to provide a 
little more than one half (56% to 59%) of required blood flow to sustain the patient’s needs, 
leading to the intuitive conclusion that the LVAD may not be appropriate as a bridge to recovery 
treatment for patients with severe heart failure. 
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Table 6.1: pump power ( EP ) and pump speed ( ) values of the nine different cases to keep the aortic valve 
open during 15% of the duration of the corresponding cardiac cycle. 
 
Level of Heart Failure 
maxE =1.00 maxE =0.75 maxE =0.50 
L
ev
el
 o
f 
p
h
y
si
ca
l 
A
ct
iv
it
y
 
120bpm
0.5mmHg.s/mlS
HR
R

  
1.39EP W  
9,141rpm   
1.02EP W  
8,503rpm   
0.59EP W  
7,470rpm   
75bpm
1.0mmHg.s/mlS
HR
R

  
0.57EP W  
8,553rpm   
0.4EP W  
7,838rpm   
0.23EP W  
6,917rpm   
60bpm
1.2mmHg.s/mlS
HR
R

  
0.4EP W  
8,338rpm   
0.28EP W  
7,693rpm   
0.14EP W  
6,672rpm   
 
 
Table 6.2: Blood flow required for healthy patient and blood flow produced for the nine different when the 
aortic valve open during 15% of the duration of the corresponding cardiac cycle 
 
Blood flow for healthy heart and different levels of heart failure 
maxE =2.00 
mmHg 
maxE =1.00 
mmHg 
maxE =0.75 
mmHg 
maxE =0.50 
mmHg 
L
ev
el
 o
f 
p
h
y
si
ca
l 
A
ct
iv
it
y
 
120bpm
0.5mmHg.s/mlS
HR
R

  
9.30 l/min 
100% 
 
8.22 l/min 
88% 
7.04 l/min 
76% 
 
5.39 l/min 
58% 
 
75bpm
1.0mmHg.s/mlS
HR
R

  
4.90 l/min 
100% 
4.46 l/min 
91% 
3.77 l/min 
77% 
 
2.88 l/min 
59% 
 
60bpm
1.2mmHg.s/mlS
HR
R

  
4.30 l/min 
100% 
3.74 l/min 
87% 
3.18 l/min 
74% 
5.40 l/min 
56% 
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6.3.  Preliminary results in detecting the aortic valve opening 
In order to be able to maintain regular opening of the aortic valve during LVAD support, 
a feedback controller that can keep the pump motor power below the critical value ( c
EP ) must be 
developed. This controller should utilize a feedback variable from the pump signals or the 
cardiovascular system to detect the opening (or the permanent closure) of the aortic valve. In this 
research we present the systemic vascular flow as a good candidate to be the feedback signal. 
This signal is selected mainly because of two reasons: (1) measuring this signal can be done 
easily in real time through a flow sensor cuff placed on the arm of the patient, and (2) This signal 
pattern noticeably changes when the aortic valve experiences permanent closure. 
The systemic vascular flow (denoted as RSI ) is the total flow through the systemic 
circulation and is represented in the mathematical model as the current that flows through SR (see 
Figure 2.3) this flow can be calculated in the model as: 
3 2( ) ( )
RS
S
x t x t
I
R

          (6.1) 
Or alternatively as: 
3
5
( )
( )RS S
dx t
I x t C
dt
          (6.2) 
Figure 6.6 shows the systemic vascular flow signals for the case of a mild heart failure 
and moderate level of activity, within three cardiac cycles, for different values of EP . In Figure 
6.6 (a) – (c) (blue plots) the pump motor power values used are 1.4W, 1.1W and 0.8W, 
respectively. All these values are high enough to cause the permanent closure of the aortic valve 
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(see Figure 6.3 and Table 5.2), in fact one of the pump motor power values (
EP =0.8W) is the 
critical pump motor power ( c
EP ). The systemic vascular flow signals in these three plots have 
two peaks during each cardiac cycle; one of these peaks is distinctively higher than the other. 
This is remarkably different than the signals shown when lower pump motor power values (i.e. 
less than c
EP ) are used. Figure 6.6 (d)-(e) show the systemic vascular flow (in red plots) when 
pump motor power is set to 0.6W and 0.3W, respectively. In these cases, the difference between 
the two peaks in value is much smaller than the previous cases [70]. 
Figure 6.7-Figure 6.9 show that this signal pattern is consistent in all the nine cases we 
presented in Table 5.1. The three figures represent the three level of heart failure severity, while 
each figure has three subplots to represent the three levels of activity: (a) active, (b) moderately 
active, and (c) inactive. The range and step increase of the pump motor power in each case were 
changed to guarantee that the critical pump power (
E
cP ) value is used (shown in dashed blue 
trace), in addition to two other values (shown in dashed blue trace also) greater than 
E
cP and other 
two below 
E
cP  (shown in solid red trace).  
These plots further support the claim that it is easier to detect the aortic valve opening 
and develop a controller for keeping the aortic valve dynamics normal in patients with mild heart 
failure. As seen in Figure 6.7-Figure 6.9, the vertical separation between the two peaks when the 
patient has a mild heart failure is greater than that of the other two cases of heart failure severity. 
Additionally, within each level of heart failure severity, this vertical separation increases as the 
level of activity increases. This concludes to the fact that an active patient with mild heart failure 
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is the most obvious case (between the nine cases) for a controller to easily detect the aortic valve 
permanent closure occurrences. 
Again the case of a mild heart failure and moderate level of activity case is used as a 
representative case to highlight another significant pattern in the systemic vascular flow signal. 
Figure 6.10 is the same as Figure 6.7(b), but with a wider range of pump motor power values 
used and a smaller step. The range of 
EP that is used in this simulation starts from 0.2W to 1.6W, 
with a step of 0.1W. The solid red traces in the figure represent the pump power values below c
EP . 
These flows seem to share the first of the two peaks in the flow during each cardiac cycle (see 
the arrow labeled 1P in the figure). The dashed blue traces are the flows that cause the aortic 
valve permanent closure to happen, and it can be seen that they neither share the first nor the 
second peak of the flow. 
Finally, Figure 6.11 shows the systemic vascular flow of healthy heart (The 
cardiovascular model introduced in chapter one was used). This signal resembles the systemic 
vascular flow of heart failure patients when the aortic valve is operating normally, although in 
the case of healthy heart, it can be seen that the first peak is greater than the second peak. 
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(d) 
 
(e) 
Figure 6.6: Systemic vascular current signal for mild heart failure with moderate level of activity. Pump motor 
power values shown are (a) 
EP =1.4W, (b) EP =1.1W, (c) EP =0.8W, (d) EP =0.6W and (e) EP =0.3W 
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(a) 
 
(b) 
 
(c) 
Figure 6.7: Systemic vascular of patient with mild heart failure and different levels of activity: (a) active, (b) 
moderately active, and (c) inactive. 
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(a) 
 
(b) 
 
(c) 
Figure 6.8: Systemic vascular of patient with moderate heart failure and different levels of activity: (a) active, 
(b) moderately active, and (c) inactive. 
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(b) 
 
(c) 
Figure 6.9: Systemic vascular of patient with severe heart failure and different levels of activity: (a) active, (b) 
moderately active, and (c) inactive. 
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Figure 6.10: RSI for mild heart failure and moderate level of activity. EP range is from 0.2W to 1.6W . 
 
 
 
 
Figure 6.11: Systemic vascular flow for healthy heart with no LVAD used 
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6.4. Summary 
In this chapter, we used the data and simulation results from chapter five to further 
explore the effect of the aortic valve dynamics on the bridge to recovery treatments. The 
problems that occur because of the permanent closure of the aortic valve are listed. The aortic 
valve frequent opening was presented as a solution for these problems. Aortic valve opening 
duration is examined as the pump motor power is increased. The results show that the active 
patient with mild heart failure case has the highest pump motor power value at which the 
permanent closure occurs. This essentially means that the pump can be operated in a wide range 
of values while the aortic valve is opening every cardiac cycle. Finally, we presented simulation 
results suggesting that the systemic vascular flow is a good candidature to be a feedback variable 
for a controller that can keep the aortic valve dynamics operating normally. 
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CHAPTER 7: SUMMARY, CONCLUSION AND FUTURE WORK 
In this chapter, we summarize the research work while highlighting the conclusions that 
have been made in this dissertation. This chapter also presents possible future work directions 
where improvements are needed to shape the work presented here in a more practical form. 
7.1. Summary and conclusion 
The research presented in this dissertation attempted to provide a treatment-specific 
approach in the analysis and control of the LVAD in a heart failure patient. A modified 
combined cardiovascular-LVAD model that can accurately represent the system was used in 
obtaining the simulation results. 
First, an introduction about cardiovascular system was presented in Chapter One. An 
overview of the heart, cardiac cycle and different circulations was discussed from the 
physiological point of view. Then we reviewed a previously developed fifth order model of the 
cardiovascular system that focuses on the left side of the heart.  
In the second chapter we reviewed the heart failure problem and the different treatment 
options. One of these treatment options is the use of the LVAD, which is the main focus of this 
research. We explained the differences between the two generations of the LVAD, the different 
components of the device, and the treatment strategies of the LVAD usage. We continued to 
build on the model presented in Chapter One by adding the LVAD pump model in parallel to the 
native left ventricle of the patient. This resulted in the combined cardiovascular-LVAD system. 
This model used the pump speed as the control variable. It is important to note that this 
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combined (i.e. the cardiovascular-LVAD system) model was completely developed by a 
previous work of another research group. 
In Chapter Three, we improved this model by selecting the pump motor power to be the 
control variable of the model. This is the first contribution of the dissertation, since the 
introduction of the pump motor power, instead of the pump speed, as the control variable made 
the existing model more practical. It may be acceptable from a theoretical perspective to have the 
pump speed as the control variable, but in reality the pump is controlled by the supplied power to 
the LVAD pump motor. We reformulate the sixth order model to have the pump motor power as 
the independent control variable. The relationship between the pump motor power and the pump 
speed was shown to be non-linear and is influenced by the pump flow. Simulation results 
concluded that the pump speed signal pattern changes as the LVAD operates in the suction range. 
Another conclusion from the simulation results was the effect of the severity of the heart failure 
on the pump speed and the pump flow signals. It was shown that the higher the value of 
maxE
(which is a representation of the contractility of the heart muscle), the larger the amplitude of 
both the pump speed and pump flow signals, while the pump power is kept constant. This 
essentially means that with the control variable of the pump being constant, the patient with less 
severe heart failure condition will have more blood flow as a result of the heart muscle ability to 
pump more blood. 
Chapter Four presented the development of a feedback control that can be used in the 
bridge to transplant and destination therapy. This feedback controller is the second contribution 
by this dissertation. In this controller, the feedback variable is the spontaneous change (i.e. when 
pump motor power is kept constant) in the pump flow when the activity level of the patient 
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changes. When the controller detects a change in the pump flow, without any change in the pump 
motor power, an algorithm is employed to find the new 
SR value that resulted from the change of 
the activity level. It should be noted here that 
SR is the representation of the activity level of the 
patient in the model. Once 
SR is identified, it is used in the fifth order model to calculate the 
physiological demand of blood flow of a health individual under the same level of activity. This 
physiological demand becomes the new blood flow target of the controller. The controller will 
use an optimization function to minimize the difference between the current pump flow and the 
target pump flow. 
The third, and last, contribution of this research is presented in Chapters Five and Six. 
Chapter Five focuses, in general, on the effect of the pump performance on the aortic valve and 
the hemodynamic conditions of the patient. We developed a method to gather the data needed to 
study such effects, and we included a wide range of patient situations by varying 
maxE (to 
represent different levels of heart failure severity), and SR (to represent different levels of 
activity).  The simulation results showed a change in the hemodynamic signals (such as: left 
ventricular pressure, aortic valve flow, and aortic pressure), when the aortic valve is closed 
during the entire cardiac cycle, also known as permanent closure. We showed that the envelope 
of the maximum values of the pump flow signal is continuously increasing as the pump motor 
power is increased while the aortic valve dynamics are normal. Once the aortic valve is in 
permanent closure state, that envelope of the maximum values has a slop of approximately zero.  
Chapter Six used the data and simulation results from Chapter Five to provide a more 
detailed study on the aortic valve dynamics while focusing on the bridge to recovery treatment. 
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The permanent closure of the aortic valve can negatively impact the process of the heart recovery, 
thus we began the chapter with listing the problems associated with the valve permanent closure. 
We continued by explaining how the regular opening of the valve can contribute to avoiding the 
occurrence of such problems. The aortic valve opening duration as a percentage of the cardiac 
cycle was examined for the same patient situations listed in Chapter Five. We showed how the 
aortic valve opening percentage is comparable to that of a healthy heart when the pump motor 
power used is relatively low. The percentage decreases as we increase the pump motor power, 
until the permanent closure of the aortic valve happens when the pump motor power reaches its 
critical value. A comparison was made between the physiological demand of the patient and the 
blood flow when the pump is operated with the objective of keeping the aortic valve opening 
once every cardiac cycle. The purpose of the comparison was to show that in certain patient 
situations (such as: a patient with severe heart failure), it is not recommended to use this strategy 
(i.e. the aortic valve opening every cardiac cycle) since the critical pump motor power is so low 
that the blood flow by the pump is not sufficient for the patient. Finally, we suggested the use of 
the systemic flow signal to detect the permanent closure of the valve. This signal showed a 
different signature when the aortic valve is experiencing permanent closure. When the aortic 
valve is operating normally, the systemic vascular flow signal has two peaks with a small vertical 
separation between them. When the aortic valve is in permanent closure state, this vertical 
separation is large. Furthermore, in some cases when the pump motor power is very high, the 
first peak in the signal doesn’t exist (i.e. the signal has one peak every cardiac cycle).  
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7.2. Future work  
There are number of future research directions that can be based on the work presented in 
this research. 
First, in Chapter Three we presented interesting observation of the amplitude change of 
the pump speed and pump flow signals when 
maxE is changed. maxE is a reliable index of the 
strength of the heart muscle of the patient. Estimating 
maxE requires invasive sensors placement 
to measure pressure and flow signals [71]. Using the observation presented here in this 
dissertation, a less invasive method can be used to estimate
maxE . This will enhance the 
monitoring of the heart recovery process under the LVAD support (if the intended treatment is 
bridge to recovery). 
Second, the development of a feedback controller that can use an algorithm to detect the 
permanent closure of the aortic valve, and change the pump motor power accordingly to keep the 
normal operation of the aortic valve. Initial efforts were done in developing a detection method 
using an indicator index ( vI ) that represents the relationship between the absolute value of the 
amplitude difference between the two peaks ( 1P and 2P ) and the peak to peak amplitude ( P ) of 
the signal [72]. That is: 
2 1
v
P P
I
P



          (7.1) 
The ability of this method to detect the permanent closure of the aortic valve in 
simulation, allows it to be further validated in animal studies. Additionally, research needs to be 
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done to develop a feedback controller that can uses this method and optimally adjust the pump 
motor power to meet the criterion of bridge to recovery treatment.  
It is interesting to see that our future work focuses on the bridge to recovery treatment. 
This type of treatment has gained a lot of attention from different LVAD research groups. There 
is a great positive on the quality of life of the patient with a successful bridge to recovery 
treatment. In bridge to recovery treatment, the native heart regains its power to completely 
support the body, and then the LVAD can be removed. This treatment avoids the medical risks 
and financial burdens of having to go through heart transplant procedure (which is the case when 
the LVAD is used as a bridge to transplant device). It also avoids the inconvenience of being 
permanently supported by the LVAD device (as in the case of destination therapy), in addition to 
avoiding the risk of bleeding and thrombus formation when the LVAD is placed for a long 
period of time.    
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